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ABSTRACT 
Thanks to continuous advances in sequencing technologies, we know that a huge 
number of non-coding RNAs are transcribed from mammalian genomes. Of these, 
long non-coding RNAs (lncRNAs) represent the widest and most heterogeneous 
class. An increasing number of studies are unveiling lncRNA functions, supporting 
their active role in regulating gene expression. Regardless of lncRNAs specific 
functional features, their organization into discrete domains seems to represent a 
common denominator. Through such domains lncRNAs can recruit and coordinate 
the activity of multiple effectors, thus working as “flexible modular scaffolds”. This 
model has globally driven towards the quest for regulatory elements within 
lncRNAs, with a special attention on functional cues deriving from RNA folding. 
Since transposable elements (TEs) represent 40% of nucleotides of lncRNA 
sequences, they have been proposed as candidate functional modules.  
Carrieri and colleagues recently reported that an embedded inverted SINEB2 element 
acts as a functional domain in antisense (AS) Uchl1, an AS lncRNA able to increase 
translation of partially-overlapping protein-coding sense Uchl1 mRNA. AS Uchl1 
regulatory properties depend on two RNA domains. A 5' overlapping sequence to the 
sense transcript is the Binding Domain (BD) and drives specificity of action. An 
embedded inverted SINEB2 element functions as Effector Domain (ED) conferring 
translational activation power. AS Uchl1 is the representative member of a new class 
of lncRNAs, named SINEUPs, as they rely on a SINEB2 element to UP-regulate 
translation. AS Uchl1 activity can be transferred to a synthetic construct by 
manipulating the AS sequence in the BD, suggesting the potential use of AS Uchl1-
derived synthetic SINEUPs as tools to increase translation of selected targets. 
This work was the first example of a specific biological function assigned to an 
embedded TE leading to the hypothesis that embedded TEs provide functional 
modules to lncRNAs. 
A major limit to the application of SINEUPs is represented by the poor knowledge of 
the basic mechanisms underlying the biological activity of the ED. A crucial 
challenge becomes the identification of secondary structures that may confer 
characteristic protein binding properties. Protein partners would modulate SINEUPs 
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action and contribute to achieve specific functional outputs.  
In this thesis, I focus on understanding the molecular basis of SINEUPs activity in 
cells and I discuss the potential applications of synthetic SINEUPs as translation 
enhancers.  
First, I investigated the structural basis for translation activation mediated by the ED 
of SINEUPs. I pointed out that specific structural regions, containing a short terminal 
hairpin, are involved in the ability of natural and synthetic SINEUPs to increase 
translation of target mRNAs. 
Next, I identified protein partners modulating the activity of SINEUPs in cells. I 
found that AS Uchl1 interacts with the interleukin enhancer-binding factor 3 (ILF3) 
and that the presence of the inverted SINEB2 favors binding in vivo. In particular, I 
demonstrated that the AS Uchl1-embedded TEs, inverted SINEB2 and Alu, direct 
AS Uchl1 localization to ILF3-containing complexes, thus contributing to AS Uchl1 
bias towards nuclear localization. I thus suggest that nuclear retention could 
represent a possible mechanism regulating SINEUP activity. 
I also validated the scalability of synthetic SINEUPs as tools to increase protein 
synthesis of targets of choice. I showed that SINEUP technology can be adapted to a 
broader number of targets, with interesting potential applications in different fields, 
from biotechnology to therapy. SINEUPs function in an array of cell lines and can be 
efficiently directed toward N-terminally tagged proteins. Their biological activity is 
retained in a miniaturized version within the range of small RNAs length. Their 
modular structure can be exploited to successfully design synthetic SINEUPs against 
selected endogenous targets, supporting their efficacy as tools to modulate gene 
expression in vitro and in vivo. Hence, I propose SINEUPs as versatile tools to 
enhance translation of mRNAs of choice. 
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ABBREVIATIONS 
 
ADAR adenosine deaminase acting on RNA 
AS antisense 
BD binding domain 
bp base pair 
cDNA complementary DNA 
ceRNA competing endogenous RNA 
ciRNA circular RNA 
ds double-stranded 
dsRBD double-stranded RNA-binding domain 
dsRBM double-stranded RNA-binding motif 
ED effector domain 
ENCODE Encyclopedia of DNA Elements 
eRNA enhancer RNA 
FANTOM Functional Annotation of the Mammalian Genome 
FBS fetal bovine serum 
FCS fetal calf serum 
HRP horseradish peroxidase 
IF immunofluorescence 
IP immunoprecipitation 
k kilo 
lincRNA long intergenic non-coding RNA 
LINE long interspersed elements 
lncRNA long non-coding RNA 
LTR long term repeat 
miRNA micro RNA 
mRNA messenger RNA 
MS mass spectrometry 
ncRNA non-coding RNA 
NGS next generation sequencing 
nt nucleotide 
ORF open reading frame 
PD Parkinson's disease 
qRT-PCR quantitative real time PCR 
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 RBP RNA-binding protein 
RIDome RNA-interacting domainome 
RNA Pol RNA polymerase 
RNP ribonucleoprotein 
RNRE ribonuclear retention element 
rRNA ribosomal RNA 
RT retrotranscriptase 
S sense 
SINE short interspersed element 
siRNA short-interfering RNA 
snoRNA small nucleolar RNA 
ss single-stranded 
TE transposable elements 
tRNA transfer RNA 
Uchl1 Ubiquitin carboxyl-terminal esterase L1 
WB western blot 
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INTRODUCTION 
The central “dogma” of biology states the unidirectional flow of information from 
gene sequence to protein product (Crick, 1958). According to this vision, the genetic 
information is encoded in DNA, transcribed to form messenger (m) RNA molecules 
which are eventually translated into proteins (Jacob and Monod, 1961). Thanks to 
genomic studies, we know that many exceptions to such “dogma” exist. Namely, the 
presence of a large amount of RNAs that do not template protein synthesis, but 
which unexpectedly exert essential regulatory functions in cells. Some of these non-
coding RNAs (ncRNAs) had already been spotted in the “pre-genomic era” (Salditt-
Georgieff et al., 1981; Weinberg and Penman, 1968) and were later explained by 
mRNA splicing and RNA genes with infrastructural and regulatory roles (i.e. 
ribosomal RNA -rRNA-, transfer RNA -tRNA-, RNAse P, SRP-7S). However, for 
many others, decades were to pass before getting to their isolation and understanding 
of their function. Pioneer genetic studies in the early nineties unveiled the presence 
of large regulatory ncRNAs involved in imprinting and other cellular processes 
(Brown et al., 1992; Huarte and Marín-Béjar, 2015). Almost in parallel, small 
ncRNAs (microRNAs -miRNAs- and interfering RNAs) were discovered to 
modulate gene expression by interfering with mRNAs transcription or translation 
(Hamilton and Baulcombe, 1999; Lagos-Quintana et al., 2001; Lee et al., 1993). The 
development of full genome sequencing techniques made it possible to survey the 
transcriptomes of many organisms at an unprecedented degree. In this context, large 
genomic projects, such as FANTOM (Carninci et al., 2005; FANTOM Consortium 
and the RIKEN PMI and CLST (DGT) et al., 2014) and ENCODE (ENCODE 
Project Consortium, 2004; Derrien et al., 2012) marked the beginning of the so called 
“post-genomic era”. These studies provided the scientific world with the astonishing 
knowledge that the majority (70-80%) of the mammalian genome is transcribed, but 
that only a tiny part (1-2%) of the transcriptionally active regions correspond to 
protein-coding genes. Indeed, pervasive transcription produces a vast repertoire of 
ncRNAs of all sizes and shapes, including small ncRNAs, long non-coding RNAs 
(lncRNAs) and RNAs of Transposable Elements (TEs). Globally, ncRNAs have been 
shown to play crucial roles in generating a previously underestimated complexity in 
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gene regulatory networks. In this context, the past decade has seen a strong interplay 
between method development, exploration and discovery about RNA biology.  
1 LncRNAs  
Among ncRNAs, long (or large) non-coding RNAs represent the widest and most 
heterogeneous class. By definition, lncRNAs are transcripts exceeding 200 
nucleotides (nt) in length, with no significant protein coding capacity. According to 
LNCipedia v3.1, the human genome counts more than 90000 lncRNAs, with their 
number increasing almost in a daily basis (Iyer et al., 2015; Volders et al., 2015). 
The majority of lncRNAs share some basic features of mRNAs: they are transcribed 
by RNA polymerase II, they undergo splicing, present 5′ caps and are polyadenylated 
(Guttman et al., 2009). However, what allows the cells to distinguish them from 
mRNAs, except for the lack of coding potential, is still an open question. 
Computational approaches combined with gain/loss-of-function studies have 
contributed to reveal a close association between lncRNAs and protein-coding 
transcripts expression patterns, thus providing precious cues on lncRNAs function 
(Guttman et al., 2009). It is nowadays extensively acknowledged that lncRNAs 
contribute to gene expression regulation through an array of different mechanisms 
that depend on their anatomical properties, their subcellular localization and the 
interactions with other molecular elements. Examples of lncRNAs intervening in 
transcriptional and translational regulation, cellular trafficking, nuclear organization 
and compartmentalization have been shown (Huarte and Marín-Béjar, 2015). 
Moreover, lncRNAs have been reported to be involved in normal organism 
development as well as in disease (Fatica and Bozzoni, 2013; Chen et al., 2016; 
Sánchez and Huarte, 2013).  
Although the list of lncRNAs involved in arguably important biochemical, cellular, 
and developmental activities is steadily growing, our knowledge of the mechanisms 
regulating their biological activity is still limited.  
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1.1 Classification of lncRNAs 
LncRNAs represent the most heterogeneous class of ncRNAs, including an array of 
transcripts differing in size, anatomical properties, sequence content, subcellular 
localization and biological function. Accordingly, different criteria can be adopted 
for their classification. 
Anatomical properties 
A first classification of lncRNAs can be carried out on the basis of the genomic 
location relative to their neighbouring protein-coding genes. LncRNAs can thus be 
intergenic (referred to as long intergenic non-coding RNAs or lincRNAs) if they do 
not overlap with any other gene or, alternatively, may overlap to genes in exonic, 
intronic or fully overlapping configuration. In particular, antisense (AS) lncRNAs are 
transcribed from the opposite DNA strand overlapping with exons of a protein-
coding gene.  
Subcellular localization 
Conversely to mRNAs, which are predominantly localized in the cytoplasm, 
lncRNAs may be assigned to different subcellular compartments and, accordingly, 
exert specific functions. Hence, it is possible to distinguish nuclear and cytoplasmic 
lncRNAs. 
A considerable portion of well characterized lncRNAs is nuclear and exert functional 
roles within the nucleus, in cis or trans. Nuclear lncRNAs can regulate transcription 
(Vance and Ponting, 2014), provide structural components of specific subnuclear 
compartments (Fox and Lamond, 2010) and contribute to shape chromatin 
organization (Hacisuleyman et al., 2014). Some lncRNAs reside instead in the 
cytoplasm, where they contribute to post-transcriptional gene expression regulation 
by “sponging” miRNAs, by sequestering specific proteins or by modulating 
translation (Carrieri et al., 2012; Cesana et al., 2011; Liu et al., 2015; Tichon et al., 
2016). Interestingly, examples of lncRNAs shuttling across different cellular districts 
in response to specific stimuli have been reported as well (Carrieri et al., 2012; Kino 
et al., 2010). Although a link between lncRNAs localization and function is 
supported by different reports (Chen, 2016), the specific mechanisms determining 
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lncRNAs subcellular fate are still obscure. A major issue towards a comprehensive 
understanding of lncRNAs regulatory activity concerns the code of rules dictating 
localization. In this context, a number of studies have focused on high-throughput 
characterization of lncRNAs localization patterns by combining computational 
approaches with high-resolution single-molecule imaging techniques (Cabili et al., 
2011, 2015; Djebali et al., 2012). Although lncRNAs seem to be predominantly 
nuclear, recent reports showed that cytoplasmic lncRNAs are actually more abundant 
than expected and, almost paradoxically, can physically interact with ribosomes (van 
Heesch et al., 2014; Ingolia et al., 2011). In particular, Carlevaro-Fita and colleagues 
pointed out some specific characteristics of ribosome-interacting lncRNAs, such as 
capping, 5'UTR length and depletion of retrotransposons, stressing that intrinsic 
features of lncRNAs seem to affect their localization (Carlevaro-Fita et al., 2016). 
Indeed, the presence or absence of specific sequence and structure elements within 
lncRNAs have been shown to have a say in determining lncRNAs subcellular fate 
(Chen, 2016). For example, nuclear retention signals can be stored within lncRNAs 
primary sequence. Often intron-containing or intron-derived transcripts show a bias 
towards nuclear localization, such as circular intronic RNAs (ciRNAs) (Zhang et al., 
2013), which control transcription of parent protein coding genes in cis, and 
lncRNAs with snoRNA ends (sno-lncRNAs), which accumulates at their 
transcription and processing sites within the nucleoplasm (Yin et al., 2012). 
Occasionally, some divergently transcribed lncRNAs as Khps1 may form a DNA-
RNA triplex with double-stranded DNA thus being trapped closed to their gene loci 
(Postepska-Igielska et al., 2015). Furthermore, many are the examples of lncRNAs 
with structural features affecting subcellular localization, which result in restricting 
their action to specific compartments. Highly-structured domains can be identified in 
a subset of nuclear lncRNAs which have been or might be implicated in localization, 
as shown for Kaposi's sarcoma-associated herpesvirus PAN lncRNA's, which 
contains a U-rich internal loop determining its nuclear retention (Mitton-Fry et al., 
2010). Notably, lncRNAs structures can mediate the association with molecular 
partners, either chromosomes or protein complexes, dictating their subcellular fate. 
Possible mechanisms determining lncRNAs nuclear retention are summarized in 
Figure 1. 
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Figure 1. Mechanisms of lncRNAs nuclear retention. Multiple factors can be involved in lncRNAs 
nuclear retention. Nuclear retention signals can be deposited during the assembly of nascent lncRNPs 
(I). Upon lncRNP maturation, ribonuclear retention elements (RNRE; II) contained in lncRNAs may 
associate with nuclear matrix proteins (III) to constrain lncRNAs in the nucleus. Functional domains 
(IV) of lncRNAs may recruit chromatin modifying complexes or transcription factors or other 
structural conformation (V) of lncRNAs that may subsequently facilitate their nuclear localization in 
cis or in trans. Abbreviation: RNAP=RNA polymerase II. Modified from Chen, 2016. 
Mechanism of action 
Globally, lncRNAs can exert their regulatory actions by acting in cis or trans. 
Interestingly, despite displaying poor conservation within their primary sequences, 
there are several similarities in lncRNAs modes of action, arguing for a role of 
higher-order structures in determining function.  
Wang and Chang (Wang and Chang, 2011a) recently proposed a classification based 
on the molecular functions that lncRNAs can execute, distinguishing four main 
archetypes: signal, decoy, guide and scaffold (Figure 2). Of notice, a single lncRNA 
can match several archetypes, which are not to be intended as mutually exclusive. 
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DECOY
SCAFFOLD
GUIDE
SIGNAL
refer to chromosome
refer to protein
refer to lncRNA
refer to modified histone
refer to ribonucleoprotein
complex
refer to promoter
refer to effector molecule
 
Figure 2. LncRNAs functional archetypes. Schematic diagrams of four lncRNA archetypes. 
Decoys: acting as a ‘molecular sink’; scaffolds: providing a platform to assemble different effector 
molecules to function together; guides: binding to protein and directing the localization of the 
ribonucleoprotein complex to specific target genes; signals: function as molecular signals to indicate 
gene regulation in space and time. Modified from Chen et al., 2014. 
The first archetype includes “signal” lncRNAs, which serve as indicators of specific 
biological processes. Their transcription profiles are indeed peculiar to specific 
developmental stages, cell types or external stimuli. In this way, such lncRNAs 
coordinate gene expression in a specific time window, in a given cell population or 
during adaptive responses to environmental changes. Some of these transcripts exert 
regulatory functions by establishing physical interactions with genes, proteins or 
other transcripts; others are instead only by-products of transcription, and it is the 
transcriptional process itself which becomes regulatory. For example, lncRNAs such 
as Kcnq1ot1 and Air mediate the transcriptional silencing of multiple genes by 
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interacting with chromatin and recruiting the chromatin modifying machinery in an 
allele-specific manner (Mohammad et al., 2009). A different role is carried out by 
lncRNAs from the mammalian Hox loci: HOTAIR, Frigidair and HOTIP, which act 
as signals for anatomical position. Their expression was indeed found to be co-linear 
with the overall anatomic expression pattern of the HOX loci (Rinn et al., 2007).  
The use of an RNA intermediate to convey information instead of a protein 
represents an advantage especially when cellular responses have to be fast, as 
translation times are bypassed. This is the case of two lncRNAs which are induced 
by p53 and involved in regulation of p53 transcriptional response to DNA damage: 
lincp-21 (Huarte et al., 2010) and PANDA (Hung et al., 2011). Finally, a new class 
of ncRNAs—enhancer or eRNAs—have been described that are produced by 
activity-dependent RNA polymerase II binding of specific enhancers (Kim et al., 
2010). Enhancers have a more active “promoter-like” role in regulating gene 
expression. The level of eRNA expression at these enhancers positively correlates 
with the level of messenger RNA synthesis at nearby genes, suggesting an active 
engaging of these in promoting mRNA synthesis (Kim et al., 2010; Wang and 
Chang, 2011).  
LncRNAs fulfilling the second archetype work as “decoys”, acting as molecular 
sinks for diverse factors. Several examples involve lncRNAs as negatively regulator 
of an effector. They may target the ability for transcription factors to induce 
transcription, as in the case of the lncRNA Gas5 on the glucocorticoid receptor (Kino 
et al., 2010). Moreover, they may act as “sponge” of miRNAs activity (Poliseno et 
al., 2010), which are thus sequestrated and prevented from exerting their function. 
“Guide” lncRNAs represent the third archetype: these transcripts bind proteins and 
subsequently drive their localization to specific targets. With this mechanism, 
ribonucleoprotein complexes are recruited to DNA, resulting in modulation of gene 
expression and epigenetic changes. Examples of these RNAs acting either in cis or in 
trans have been provided. Irrespective of the adopted mechanism, target gene 
expression can be both repressed or enhanced.  An example of cis regulation is the 
mechanism of mammalian X inactivation. The mammalan X inactivation center 
(Xic) (Plath et al., 2002) controls the silencing of one of the two X chromosomes in 
female mammals. This is achieved by the recruitment of Polycomb repressive 
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complex 2 (PRC2) on the extra X-chromosome, brought in cis by RepA ncRNA 
originating from the 5’end of Xist (Wutz et al., 2002). This results in the creation of a 
“heterochromatic state” (Sun et al., 2006) that is required for transcriptional 
induction of Xist, followed by the recruitment of Polycomb and their associated 
chromatin modifications to the inactive X chromosome (Xi). An example of cis-
accumulating lncRNA acting in trans is represented by FIRRE lncRNA 
(Hacisuleyman et al., 2014), which is transcribed from the X chromosome and 
involved in the formation of five trans-chromosomal contacts at its site of 
transcription. This 3D organization of chromosomes enables long-range interactions 
between the regulatory genomic elements and the target gene locus. 
The fourth and last archetype comprehends the most complex functional class, that is 
“scaffold” lncRNAs. In this model, lncRNAs provide the core element on which 
specific molecular components are brought together. Scaffold lncRNAs can 
simultaneously contact different effectors through different discrete domains, thus 
dictating and coordinating the dynamics of intermolecular interactions and signalling 
events (Spitale et al., 2011; Rinn and Guttman, 2012). Globally, this concept relies 
on the ability of RNA to interact with DNA, RNA and proteins as well. A 
characteristic example of lncRNAs working as scaffold is provided by the telomerase 
complex. This is a conserved reverse transcriptase involved in maintenance of 
genome stability by adding back telomeric DNA repeats lost from chromosome ends 
(Lustig, 2004). Its catalytic activity requires the association of two subunits: an 
integral RNA subunit, the telomerase RNA (TERC), that provides the template for 
repeat synthesis, and a catalytic protein subunit, the telomerase reverse transcriptase 
(TERT). The TERC, in particular, also possesses structures that contribute to TERT 
binding and catalytic activity, in addition to those that play major roles in stability of 
the complex (Collins, 2008). Of notice, Zappulla and Cech demonstrated that protein 
interaction domains in yeast telomerase RNA can be swapped and spacer regions 
deleted with almost no impact on RNA function, further supporting a role of flexible 
scaffold bringing together diverse proteins (Zappulla and Cech, 2004). Further 
examples of lncRNAs interacting with different effectors (proteins or nucleic acids) 
through specialized domains are provided by: 1. HOTAIR, containing two different 
domains for binding of polycomb repressive complex 2 (PRC2) and CoREST-LSD1 
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complex (Tsai et al., 2010); 2. Xist, harboring two independent functional domains 
mediating silencing (Rep A for PCR2) and localization (Rep C for hnRNP U and 
YY1) respectively (Wutz et al., 2002). In addition to domain architecture, lncRNAs 
can take advantage of the nucleic acid base pairing to specifically select and 
modulate target RNA and/or DNA molecules.  
Interestingly, lncRNAs association with multiple regulatory complexes has been 
observed in about 30% of embryonic stem cells (ESs) lincRNAs, suggesting a 
potentially general pattern (Guttman et al., 2011). In this context, recently Guttman 
and Rinn proposed a model according to which lncRNAs may work as key elements 
for a potential “modular RNA code” ruling cell states and biological processes 
(Guttman and Rinn, 2012). A crucial point in deciphering this code is the 
identification and characterization of key elements within lncRNAs acting as 
functional domains providing indicators of biological activity (Kapusta and 
Feschotte, 2014). 
A main issue in the investigation of lncRNAs functional domains is represented by 
their poor sequence conservation. For example, the aforementioned Xist exerts a 
conserved function in mammals; however its first exon, which contains the main 
characterized Xist functional elements, is one of the less conserved across mammals 
when sequence is considered. Rather, it has been proposed that tandem repeats in this 
region form secondary structures necessary for function, both in human and mouse 
(Duszczyk et al., 2011; Maenner et al., 2010).  
Different studies showed that secondary and tertiary structures seem to be much 
more conserved throughout different lncRNAs than primary sequence, suggesting a 
strict link between structure and function (Li et al., 2016; Smith et al., 2013). 
Structures can be neutral to certain mutations and permit interactions with proteins or 
other nucleic acids. Interestingly, lncRNAs seem to be characterized by a higher 
degree of structuring compared to protein-coding transcripts (Incarnato et al., 2014), 
which predominantly owe their biological activities to conserved sequence domains. 
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2 TEs  
Long chromosomal regions which are not occupied by genes, intergenic regions and 
introns are covered with thousands of repetitive DNA sequences, most of which are 
mobile genetic elements or TEs. TEs are DNA sequences capable of moving and 
integrating into new genomic locations. They are diffused in all eukaryotic genomes 
and constitute between one and two thirds of the entire human genome (de Koning et 
al., 2011; Lander et al., 2001). 
TEs have been often presented as “genomic parasites”, due to the detrimental effects 
often associated to their mobilization. The organisms' interactions with TEs curiously 
resemble the host-pathogen co-evolution, with cells being continuously engaged in a 
genetic “arms race” with endogenous retrotransposons (Dawkins and Krebs, 1979; 
Goodier, 2016). To this, host genomes have constantly evolved new strategies to 
fight TEs mobilization and, TEs, on their behalf, have contrived ways to escape such 
control (Kato et al., 2007). Indeed, some copies of the TEs might retain limited 
activity bypassing their extinction, as a consequence of the accumulation of neutral 
mutations. While deleterious mutations are promptly eliminated by selection, neutral 
ones can occasionally turn out to be beneficial. Accordingly, despite their parasitic 
nature, TEs can rather be seen as genomes' symbionts (Elbarbary et al., 2016; 
Goodier, 2016). 
Previously considered as genomic “junk”, TEs are now known to play pivotal roles 
in shaping genomic complexity and dynamicity thanks to their ability to occasionally 
introduce functional sequence elements at their insertion sites  (Cordaux and Batzer, 
2009; Elbarbary et al., 2016). Material deriving from TEs has been constantly 
“recycled” by host genomes for the most diverse purposes. As a result, TEs play a 
crucial role in regulation of gene expression at different levels. TEs can work as 
functional DNA elements, like promoters or enhancers (Bejerano et al., 2006; 
Faulkner et al., 2009; Su et al., 2014) and drive the expression of downstream genes. 
Often, they provide interfaces for binding with transcription factors or chromatin-
remodelling complexes (Bourque et al., 2008; Lynch et al., 2011; Wang et al., 2007). 
Furthermore, TEs can be “exonized” in transcripts, giving rise to regulatory RNA 
domains as well. They can promote alternative splicing of pre-mRNAs (Lev-Maor et 
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al., 2008; Sorek et al., 2002) or, when embedded in 3′ UTRs of mRNAs, affect their 
stability (An et al., 2004). Phylogenetic analysis showed that different TEs have 
contributed to the rise of mRNAs polyadenylation sites through the course of 
evolution (Lee et al., 2008). Furthermore, embedded retrotransposons can provide 
miRNA-binding sites in target mRNAs (Piriyapongsa et al., 2007). Interestingly, a 
growing body of evidence suggests that embedded TEs can confer specific functional 
features to lncRNAs as well (Johnson and Guigó, 2014). Accordingly, several TE 
families are enriched in lncRNAs, with consistent interspecific variation in the 
coverage and types of TEs (Kapusta et al., 2013; Kelley and Rinn, 2012; Kim et al., 
2016). Over two thirds of mouse and human lncRNA sequences harbor 
retrotransposon insertions (Kapusta et al., 2013; Volders et al., 2015), that is a 
considerably higher percentage compared to protein-coding sequences, untranslated 
regions or small RNAs (Kapusta et al., 2013). More interestingly, the association of 
retrotransposons with promoters, TSS or polyA sites is by far more frequent in 
lncRNAs than in protein-coding mRNAs, in both species. Enrichment patterns of 
different TEs classes seem to be conserved in mouse and human lncRNAs, with 
ERVs being the most enriched class. An exception is provided by SINEs, which are 
less diffused in human, but enriched in mouse lncRNAs (Kelley and Rinn, 2012). 
These observations suggest a strong contribution of TEs in lncRNAs evolution and 
function (Kapusta et al., 2013). For this, they have been recently proposed to 
represent the molecular basis of domain organization in lncRNAs (Carrieri et al., 
2012; Zucchelli et al., 2015a; Johnson and Guigó, 2014; Kapusta and Feschotte, 
2014). 
2.1 Classification of TEs 
According to the mechanism adopted to mobilize, TEs are divided into two main 
classes (Huang et al., 2012). In particular, DNA transposons (class II) encode a 
transposase enzyme which catalyzes their “cut and paste” into new genomic sites; 
retrotransposons (class I) are instead firstly transcribed into an RNA intermediate, 
which is subsequently retrotranscribed and integrated at a different site of the 
genome (“copy and paste”) (Wicker et al., 2007). Retrotransposons constitute the 
most abundant class of TEs and, conversely to DNA transposons, are limited to 
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eukaryotes. Three subclasses can be distinguished: long terminal repeat (LTR) 
elements, Long INterspersed Elements (LINEs) and Short INterspersed Elements 
(SINEs).  
LTR elements are autonomous retrotransposons evolved from retroviruses and, as a 
consequence, resemble these in terms of genomic structure and mechanism of 
amplification. They are 5-12 kilobases (kb) long and contain LTRs flanking an ORF 
encoding for an RNA-dependent DNA polymerase (retrotranscriptase, RT), which 
catalyzes their amplification (Havecker et al., 2004). Although a variety of LTR 
retrotransposons exist, only the vertebrate-specific endogenous retroviruses (ERVs) 
appear to have been active in mammalian genomes (Lander et al., 2001).  
Unlike LTRs, LINEs and SINEs lack terminal repeats and are globally referred to as 
non-LTR retrotransposons.  
LINEs are autonomous retrotransposons of 6 kilobases (kb) widespread among 
eukaryotic genomes. In particular, LINE-1s (L1s), which represent the only active 
subfamily in mammals, occupy the 19% and 17% of mouse and human genomes, 
respectively (Ostertag and Kazazian, 2001). Retrotransposition-competent LINE-1s 
encode the machinery necessary to support their own replication. A typical L1 
transcript contains two open reading frames, ORF1 and ORF2. ORF1 encodes a 40 
kDa protein (ORF1p) with RNA-binding activity, while ORF2 encodes a 150 kDa 
protein (ORF2p) with endonuclease and reverse-transcriptase activity. The LINE-1 
endonuclease domain is responsible for the dsDNA break at the insertion target site, 
whereas the reverse transcriptase (RT) activity generates the cDNA copy of LINE-1 
to be inserted into the new genomic location (Ostertag and Kazazian, 2001).   
SINEs are non-autonomous retrotransposons ranging from 85 to 500 bases in length. 
Eukaryotic genomes can contain tens or hundreds of thousands of SINE copies 
(Deragon and Zhang, 2006; Kramerov and Vassetzky, 2005).  As SINEs do not 
encode for their own machinery to retrotranspose, they exploit the endonuclease and 
RT activity of a partner LINE-encoded protein (Dewannieux et al., 2003).  
LINEs and SINEs constitute about the 30% of the human genome and their 
distribution across it seems to be not casual (Lander et al., 2001). Indeed, while 
LINEs are generally found in intergenic regions, SINEs are instead abundant in gene-
rich regions (Medstrand et al., 2002). This non-random distribution may reflect a 
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selection against insertion of large LINEs sequences in correspondence of genes, 
probably to limit occasional detrimental effects. Conversely, SINEs are more likely 
to be tolerated, probably due to their smaller size, and have interestingly acquired a 
number of regulatory roles in gene expression (Lander et al., 2001). 
2.1.1 SINEs 
Like all TEs, SINE elements have been originally presented as genomic parasites 
(Doolittle and Sapienza, 1980), due to the disruptive effects on gene expression 
caused by their insertions into coding or regulatory sequences in genomes, often 
related to disease conditions. However, in some cases, their insertions within coding 
regions seem to have resulted in the rise of functional elements (Lander et al., 2001).  
SINEs are widespread among eukaryotes, even if not as wide as other TEs. They can 
be found in all mammals, reptile, fishes and some invertebrates, as well as in plants. 
Of notice, D. melanogaster species lack SINEs. In addition, SINEs are missing in 
most unicellular eukaryotes (Elbarbary et al., 2016). 
Structure and classification of SINEs 
Three parts can be typically distinguished into a SINE: a 5' head, a body and a 3'tail.  
The 5' head, which harbors the promoter, is used to classify SINEs into three 
superfamilies, according to their derivation from, and thus similarity to, cellular Pol 
III-transcribed RNAs, that is, tRNAs, 7SL RNA and 5S RNA (Kramerov and 
Vassetzky, 2011; Wicker et al., 2007). Examples of structures characterizing SINEs 
belonging to different families are reported in Figure 3. 
SINEs originating from tRNAs are particularly abundant across different organisms; 
in particular, the SINEB2s represent one of the main families in the mouse genome, 
with more than 350 000 copies.  
7SL RNA-derived SINEs have been instead identified only in rodents (Krayev et al., 
1980; Veniaminova et al., 2007), primates (Deininger et al., 1996; Zietkiewicz and 
Labuda, 1996) and tree shrews (Nishihara et al., 2002; Vassetzky et al., 2003). In 
mouse, this family encompasses the SINEB1; in human, it includes Alus. 
The number of SINE families originating from 5S rRNA is relatively small; they 
have been found in some fishes (Kapitonov and Jurka, 2003; Nishihara et al., 2006) 
and in few mammals: fruit bats (Gogolevsky et al., 2009) and springhare 
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(Gogolevsky et al., 2008). 
 
 
Figure 3. Short interspersed element (SINE) structure examples. (a) CAN, tRNA-derived SINE 
with a unique region of unknown origin and a (TC)n stretch; (b) Ther-1, tRNA-derived SINE with a 
CORE domain and a LINE-derived region; (c) Opo-1, tRNA-derived SINE with a CORE domain and 
a unique region; (d) Ped-2, tRNA-derived SINE with a bipartite LINE-derived region; (e) ID, simple 
tRNA-derived SINE; (f) Lun-1, tRNA-derived SINE with a V-domain, a (TG)n stretch, and a unique 
region; (g) B1, 7SL RNA-derived SINE with an internal duplication; (h) MEG-RL, 5S rRNA-derived 
SINE with a unique region; (i) MEN, dimeric tRNA/7SL RNA-derived SINE. Boxes with dotted 
background correspond to pol III promoter regions; ‘???’ correspond to body parts of unknown origin; 
direct repeats including terminal target site duplications are indicated by arrows. Modified from 
Kramerov and Vassetzky, 2011b. 
Similarly to the RNAs from which they derive, SINEs have an internal pol III 
promoter. The promoter in tRNA and 7SL RNA genes consists of two boxes (A and 
B) of about 11 nt spaced by 30–35 nt, while the 5S rRNA genes have three such 
boxes: A, IE and C (Schramm and Hernandez, 2002). The presence of the promoter 
within the transcribed sequence is critical for SINE amplification, as the promoter is 
preserved in new SINE copies. If SINE retrotransposition relies on Pol III, numerous 
exonic SINE copies are transcribed by Pol II within pre-mRNAs or other transcripts 
(i.e. non-coding), making nuclear RNA rich in SINEs (Kramerov and Vassetzky, 
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2005). 
The body of SINE consists of a mostly family-specific central sequence of unknown 
origin; however, part of this can contain domains shared by different SINE families 
or, as it happens more frequently and across different species, sharing sequence 
similarity with the 3'-terminal of a LINE, whose RT is exploited in SINEs 
amplification (Matveev and Okada, 2009; Ohshima and Okada, 2005). The LINE-
derived regions of SINEs can be required or not for the recognition by LINE RTs; 
accordingly, SINEs are divided into the “stringent” and “relaxed” recognition 
groups. 
SINEs 3' tail is characterized by the presence of repeated mono-, di-, tri-, tetra- or 
pentanucleotides. The tail of many SINEs is a poly(A) or irregular A-rich sequence 
(A-tail); the latter can contain the signals of transcription termination and 
polyadenylation (Borodulina and Kramerov, 2001, 2008). 
SINEs in mammalian genomes 
Almost all human SINEs belong to a single family known as Alu. They took their 
origin form the 7SL RNA gene following head-to-tail fusion and have subsequently 
amplified. Alu elements are primate-specific repeats of about 300 bp which count 
over 1 million copies in the human genome (constituting the 11% of the entire 
genome) (Lander et al., 2001).  It has been estimated a frequency of more than one 
Alu for every 3000 bp of genomic DNA; accordingly, their presence in a large 
number of genes and transcripts has been reported.  
Alus inherited the highly conserved A and B boxes from the 7SL RNA promoter 
gene. However, these elements are not sufficient to drive transcription in vivo, so 
Alus depend on flanking sequences for their expression (Figure 4). RNA Pol III-
dependent transcripts of this class are referred to as free Alus.  
Alu elements are found in gene rich regions, generally within non-coding segments 
of transcripts, such as in introns and untranslated regions, where they are transcribed 
by RNA polymerase II (Versteeg et al., 2003). In particular, “exonized” or 
“embedded” Alus can provide regulatory cis elements (Nekrutenko and Li, 2001). 
They have been associated to regulation of alternative splicing (Lev-Maor et al., 
2008; Sorek et al., 2002) and mRNAs turnover. Indeed, the poly(T) sequence that 
exists in AS Alu elements is the source of ~40% of identified 3′UTR AU-rich  
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Figure 4. Transcription of Alu elements by Pol II and Pol III. (a): Free Alu RNA. This 
hypothetical Alu element, shown in green, is transcribed by its internal Pol III promoter elements 
(Box A and Box B), which are helped by an upstream Pol III enhancer (or upstream promoter 
elements) for efficient transcription. A Pol III terminator (TTTT-3’) is depicted downstream of the 
Alu element. Both Pol III enhancer and terminator are provided by the locus of integration of the Alu 
element. The secondary structure of the resulting Alu RNA was drawn based on the secondary 
structure determined by Sinnett et al., 1991 and adapted to the sequence of the Alu element of intron 4 
of the a- Fetoprotein gene, which was shown to bind the SRP9/14 proteins. Underlined letters indicate 
the binding sites of SRP9/14 by analogy to SRP RNA. (b) Embedded Alu RNA. This hypothetical 
Alu element, shown in green, is located inside of a protein-coding gene. It might be inserted into an 
intron, a UTR, and exceptionally into a coding region. This Alu element is then transcribed by Pol II, 
embedded inside a larger transcription unit. Depending on the sequence environment, as well as on its 
own sequence, the embedded Alu RNA might adopt a typical Alu fold. Modified from Hasler et al., 
2007. 
elements (AREs), which regulate mRNA half-life through the competitive binding of 
proteins that stabilize or destabilize the transcript (An et al., 2004).  
As a consequence of the high homology among members of Alu subfamilies, Alu 
elements can trigger intermolecular pairing and double-stranded (ds) RNA formation 
(Neeman et al., 2006). In particular, human Alu elements embedded in a group of 
lncRNAs, called 1/2sbs-RNAs, provide an RNA recognition motif that base pairs 
with complementary Alu sequences in the 3’ UTRs of protein-coding mRNAs to 
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drive recruitment of STAUFEN1 (STAU1) and STAU1-mediated decay (Gong and 
Maquat, 2011). Interestingly, Alus have been shown to undergo post-translational 
modifications, such as editing. DsRNA formation triggers indeed the activity of 
adenosine deaminase (ADAR) proteins, which converts adenosine residues to 
inosines (A-to-I) (Savva et al., 2012). Athanasiadis and colleagues determined an 
interesting correlation between RNA editing and oppositely oriented Alu elements in 
close proximity. They demonstrated that each edited Alu has a reverse-oriented 
partner nearby, which appears to be edited as well. The extent of editing appears to 
depend on the distance between two inverted Alu repeats. Indeed, inverted repeated 
Alu elements (IRAlus) tend to form 300 bp long dsRNAs as a result of base-paring, 
thus triggering ADAR activity (Athanasiadis et al., 2004; DeCerbo and Carmichael, 
2005; Blow et al., 2004). It has been shown that this process extensively involves Pol 
II (but not Pol III)-transcribed Alus, which constitute the 90% of human A-to-I 
editing targets. Edited transcripts are enriched in subnuclear bodies known as 
paraspeckles. Paraspeckle protein p54nrb and its partners likely participate in the 
regulation of the nuclear/cytoplasmic distribution of IRAlus-RNAs (Chen and 
Carmichael, 2008). However, the precise role of A-to-I editing is however still 
mysterious. 
In rodents, SINE sequences occupy the 7.6% of the genome, and are found, on 
average, every few thousands nucleotides, providing potential templates for 
transcripts’ heterogeneity and ultimately molecular evolution. Two major families of 
SINEs can be identified in mouse: B1 and B2 (Krayev et al., 1982). SINEB1 
originated from 7SL RNAs. Elements of the B1 subclass named ID are involved in 
dendritic RNA localization when embedded in introns (Buckley et al., 2011). SINE 
B2s presumably derive from tRNA and have more than 350000 copies in the mouse 
genome (Kramerov and Vassetzky, 2011a). 
Similarly to human Alus, murine SINEs have been shown to provide functional 
elements involved in the regulation of diverse biological processes. Interestingly, 
Lunyak and colleagues showed that SINEB2 may serve as chromatin boundary 
elements. In particular, their bidirectional transcription causes a developmentally 
relevant change in chromatin structure, establishing a permissive environment that 
allows transcription of mouse growth hormone (GH) gene (Lunyak et al., 2007).  
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An example of conserved function of SINEs in both species is provided during stress 
response. Even if the majority of SINEs are silent in somatic tissues, stressful insults, 
like heat shock, can induce their transcription via their Pol II promoters, resulting in 
massive up-regulation of Alu and mouse B2 RNAs, which can in turn inhibit 
expression of most genes, excluding those up-regulated during heat shock, by 
binding to Pol II (Allen et al., 2004; Mariner et al., 2008). 
Collectively, human and mouse SINEs have been described to modulate protein 
translation in at least two different manners. They can act as trans regulatory factors 
when transcribed by Pol III and assembled in Alu RNP, and act as cis regulatory 
elements when transcribed by Pol II in 5′- and 3′-UTRs (Häsler and Strub, 2006; 
Lunyak et al., 2007). 
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3 SINEUPs: a new functional class of AS lncRNAs  
One of the main features of genomes is that different genes residing in opposite DNA 
strands can co-exist within the same genomic region. As a result of bidirectional 
transcription, overlapping natural sense/antisense (S/AS) pairs are generated.  
(Derrien et al., 2012; Katayama et al., 2005; Werner, 2005). In this context, AS 
transcription provides a florid source of lncRNAs in all kingdoms, from bacteria to 
humans (Lasa et al., 2012; van Dijk et al., 2011; Katayama et al., 2005).  
S/AS pairs may present all the possible combinations between protein-coding and 
lncRNAs genes and are classified according to their reciprocal genomic organization. 
In particular, 5' head-to-head divergent, 3' tail-to-tail convergent and fully 
overlapping configurations can be observed (Figure 5). 
 
 
Figure 5. Classification of sense/antisense (S/AS) pairs. Sense genes are in green, AS genes in 
purple. Arrows indicate 5′ to 3′ direction. Gray box indicates regions of overlap. Adapted from 
Zucchelli et al., 2015a. 
Of notice, approximately 61-72% of all transcribed regions in mouse and human 
present lncRNAs that are in antisense orientation to adjacent protein-coding genes 
(Katayama et al., 2005; Cheng et al., 2005). Such pairs in which a lncRNA is 
transcribed from the opposite strand of a protein-encoding gene are the most studied 
ones and, in a number of cases, these AS lncRNAs have been demonstrated to 
modulate cognate protein-coding gene expression in different modes (Pelechano and 
Steinmetz, 2013). AS lncRNAs may affect the epigenetic state of chromatin (Yu et 
al., 2008), exert transcriptional control, regulate splicing (Tripathi et al., 2010) and 
mRNAs stability (Spigoni et al., 2010). Recently, a new class of AS lncRNAs 
regulating translation of partially overlapping protein-coding transcripts has been 
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described (Carrieri et al., 2012). 
AS Uchl1 and the discovery of natural SINEUPs 
In search for AS transcripts likely to regulate the expression of Parkinson’s disease 
(PD)-associated genes, Carrieri and colleagues identified a spliced lncRNA transcript 
in the murine Ubiquitin carboxyl-terminal hydrolase L1 (Uchl1)/PARK5 gene, 
mapping in antisense orientation to its protein-coding counterpart.  
This 5' head-to-head divergent lncRNA, that initiates within the second intron of 
Uchl1 and overlaps the first 73 nt of the sense (S) mRNA including the AUG codon 
(-40/+33 from ATG) was named antisense Uchl1 (AS Uchl1). The non-overlapping 
part of the transcript contains two embedded repetitive sequences, SINEB1 of the F1 
subclass (Alu) and SINEB2 of the B3 subclass (Carrieri et al., 2012) (Figure 6).  
 
 
Figure 6. Uchl1/AS Uchl1 genomic organization. Uchl1 exons are in black: 3’ and 5’ UTRs are in 
white; AS Uchl1 exons are in gray; repetitive elements are in red (Alu) and in blue (SINEB2); introns 
are indicated as lines. Adapted from Carrieri et al., 2012. 
In mouse, AS Uchl1 is expressed 40% of tissues that expressed Uchl1 mRNA, but no 
AS Uchl1 is found in the absence of sense transcript (Carrieri et al., 2015). S and AS 
Uchl1 are highly expressed in the ventral midbrain, with a specific enrichment 
observed in dopaminergic cells. The two transcripts are localized in different 
subcellular compartments, with mature Uchl1 mRNA being predominantly detected 
in the cytoplasm, while AS Uchl1 in the nucleus.  Expression of both S and AS 
transcripts has also been reported in mouse neuronal dopaminergic cell line (MN9D) 
(Carrieri et al., 2012). 
Overexpression of AS Uchl1 in MN9D cells produces no changes in Uchl1 mRNA 
levels, but it is curiously accompanied by an increase of UCHL1 endogenous protein, 
suggesting that AS Uchl1 regulation on Uchl1 expression occurs at post-
transcriptional level (Carrieri et al., 2012).  Selective deletion of AS Uchl1 sequence 
elements lead to the identification of two functional domains responsible for AS 
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Uchl1-mediated translation upregulation, that is, the 5' overlapping region and the 
inverted SINEB2 element.  
In physiological conditions, AS Uchl1 accumulates in the nucleus of dopaminergic 
neurons, but it translocates to the cytoplasm upon cellular stress as induced by 
rapamycin, an inhibitor of CAP-dependent translation (Figure 7). Once in the 
cytoplasm, AS Uchl1 promotes translation of sense protein-coding mRNA by 
enhancing its association to heavy polysomes (Carrieri et al., 2012). Importantly, 
rapamycin-triggered increase of UCHL1 synthesis relies on the presence of a 
functional AS Uchl1. 
 
 
Figure 7. AS Uchl1 up-regulates translation of Uchl1. The 5′ region of an AS transcript to the 
ubiquitin carboxyl-terminal hydrolase L1 gene (AS Uchl1) recognizes its sense transcript and 
increases the translation efficiency of Uchl1 — an effect that depends on its SINEB2 domain. 
Modified from Pelechano and Steinmetz, 2013. 
In summary, AS Uchl1 lncRNA enhances UCHL1 translation in stress conditions 
with a post-transcriptional mechanism that requires functional overlapping and 
inverted SINEB2 sequences.  
Interrogation of FANTOM3 dataset allowed the identification of 31 natural S/AS 
pairs sharing similar features to S/AS Uchl1, that is, 5' head-to-head overlapping and 
with the AS transcript harboring an inverted SINEB2 element. Of these, AS Uxt 
proved to act similarly to AS Uchl1: its overexpression in MN9D cells triggered an 
increase of endogenous Uxt protein synthesis, with unaffected Uxt mRNA levels 
(Carrieri et al., 2012). More recently, functional validation has been successfully 
carried out for other AS RNAs in the list including AS to elastin, a secreted protein. 
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(Patrucco et al., 2015b). In this context, AS Uchl1 can therefore be considered as the 
representative member of a new functional class of natural AS lncRNAs capable of 
up-regulating translation of sense overlapping transcripts. Biological activity depends 
on the combination of two RNA elements: the overlapping region (Binding Domain, 
BD) confers target specificity while the embedded inverted SINEB2 element 
(Effector Domain, ED) is required for translation enhancement (Figure 8). These 
lncRNAs are referred to as SINEUPs, as they rely on a SINEB2 sequence to UP-
regulate translation in a gene-specific manner (Zucchelli et al., 2015a; Zucchelli et 
al., 2015b). 
 
 
Figure 8. Schematic representation of SINEUPs. SINEUP modular structure. SINEUP binding 
domain (green): SINEUP sequence that overlaps, in antisense orientation, to the sense protein-coding 
mRNA. SINEUP effector domain (yellow): non-overlapping portion of SINEUPs (gray), containing 
the inverted SINEB2 element (invB2) that confers activation of protein synthesis. 5′ to 3′ orientation 
of sense and antisense RNA molecules is indicated. Structural elements of protein-coding mRNA are 
shown: 5′ untranslated region (5′UTR, purple), coding sequence (CDS, pink) and 3′ untranslated 
region (3′UTR, light blue). Adapted from Zucchelli et al., 2015b. 
The modular organization of SINEUPs strongly reflects the role of embedded TEs in 
shaping lncRNAs functional features (Carrieri et al., 2012; Zucchelli et al., 2015a). 
In particular, TEs could provide binding sites for specific molecular complexes 
regulating SINEUP activity. At the same time, AS overlapping regions may confer 
target specificity through RNA/RNA and RNA/DNA pairing.  
However, the exact mechanism underlying the activity of the inverted SINEB2 as ED 
of SINEUPs remains elusive. 
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Synthetic SINEUPs 
The joined activity of the domains found in SINEUPs suggests the potential use of 
AS Uchl1-derived lncRNAs as enhancers of target mRNAs translation. Taken 
advantage of SINEUPs domain architecture it is indeed theoretically possible to 
design artificial SINEUPs to virtually any mRNA of choice by solely manipulating 
the BD. In particular, Carrieri and colleagues engineered a chimeric construct, named 
AS GFP, by swapping AS Uchl1 BD with a complementary sequence to EGFP 
mRNA in antisense orientation. AS GFP derives indeed from natural AS Uchl1 
deprived from its 5' end containing the overlapping sequence to Uchl1 (Δ5’ AS 
Uchl1). The whole 3' tail (about 1200 nucleotides), harboring the ED (inverted 
SINEB2) and the partial Alu repeat, is entirely kept (Figure 9).  
 
 
Figure 9. Synthetic AS lncRNA increases target protein levels. Scheme of AS GFP construct. Δ5’ 
AS Uchl1 with repetitive elements (SINEB2, red; Alu, blue) and the overlap (green) regions are 
indicated.  
Coherently with what expected, AS GFP succeeded in up-regulating GFP protein 
translation when co-transfected with corresponding sense GFP-encoding DNA in 
HEK 293T cells, with no effects on GFP mRNA levels. Further supporting SINEUPs 
action at translational level, pulse-labelling experiments showed that induction of 
GFP was due to an increase of newly synthesized protein. Interestingly, recent 
studies by Yao and co-workers showed that GFP mRNA is recruited to heavy 
polysomes in AS GFP (there referred to as RNAe)-transfected cells (Yao et al., 
2015).  
Collectively, the translational regulatory properties of natural SINEUPs are retained 
by synthetic ones, paving the way for their applications as tools to selectively 
modulate gene expression in vitro and in vivo. Furthermore, common molecular 
mechanisms are likely to be exploited.  
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The precise molecular basis of SINEUP activity remains unclear. It is conceivable 
that the formation of secondary structures could be involved, providing binding sites 
or signalling cues for recruitment of regulatory elements and molecular effectors. In 
this context, the study of the structure/function of the ED, as well as the 
identification of protein partners modulating the activity of SINEUPs would provide 
insights into the biology of these natural lncRNAs and would give essential 
information for the application of their synthetic derivatives. 
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4 RNA-protein interactions 
A growing body of literature over recent decades has shown that, in biological 
environments, RNA is regularly bound and modulated by RNA-binding proteins, 
(RBPs) (Gerstberger et al., 2014). Association with protein partners is observed 
throughout the entire life cycle of mRNAs (processing, export, localization, stability, 
translation and degradation), with significant implications in transcriptional and post-
transcriptional gene expression regulation (Glisovic et al., 2008).  
RNAs often function together with proteins in ribonucleoproteins (RNPs) providing 
dynamic structures controlling multiple cellular processes (Mitchell and Parker, 
2014; Moore, 2005). RNPs can be promptly remodelled according to the cell’s needs, 
especially under conditions that require adaptive changes (Beckmann et al., 2016).  
Even if the largest portion of published research focuses on mRNA-binding proteins 
(mRBPs) and messenger RNPs, regulation by RBPs is not limited to mRNAs, but it 
also includes processes acting on ncRNAs. Indeed, it is reasonable to assume that all 
ncRNAs rely on protein-binding to exert their functions in cells (Eddy, 2001), and 
this is true for both catalytic (rRNA, small nuclear RNAs -snRNAs- and small 
nucleolar RNAs -snoRNAs-) (Fica et al., 2013; Leung et al., 2011) and other 
regulatory RNA species (miRNAs and piwi-associated RNAs -piRNAs-) (Bartel, 
2004). In this context, the higher level of complexity characterizing lncRNAs 
regulatory pathways is known to be strictly linked to physical interactions with 
diverse proteins modulating their activity (Guttman and Rinn, 2012; Rinn and Chang, 
2012; Ulitsky and Bartel, 2013; Wang et al., 2011). Furthermore, functional features 
of lncRNAs are strictly related to the presence of complex, conserved secondary and 
tertiary structures (Li et al., 2016). Proteins, on their behalf, are prone to bind RNAs 
in correspondence of structural domains, like stem–loops and bulges (Nagai, 1996). 
Recruitment of molecular effectors thus results in the formation of ribonucleoprotein 
complexes associated with plenty of regulatory outputs (Guttman and Rinn, 2012). 
Moreover, a number of studies showed that proteins can modulate basic properties of 
lncRNAs, like stability or localization within cells, ultimately affecting their 
biological activity. Protein association could result in both a “positive” and a 
“negative” regulation of lncRNAs function. For example, hnRNP U directs FIRRE-
  30 
mediated trans-chromosomal association, by positioning the lncRNA at the site of 
action (Hacisuleyman et al., 2014). Conversely, binding with RBP HuR decreases 
lincRNA-p21 stability, thus preventing this from repressing JUNB and CTNNB1 
mRNAs translation (Yoon et al., 2012). Furthermore, proteins can work as carriers 
regulating lncRNAs trafficking across cell compartments, as recently shown for HuR 
and GRSF1, which control the nuclear export and mitochondrial localization of the 
lncRNA RMRP (Noh et al., 2016). Although the investigation of ncRNA protein 
partners represents an area of active research (McHugh et al., 2014), the full 
spectrum of ncRNAs-binding proteins is still unknown. 
Collectively, deciphering RNA/protein interactions represents a prerequisite for the 
dissection of RNA regulatory processes and, more widely, for a better understanding 
of the physiology of cells.   
4.1 RBPs 
RBPs are crucial players in gene expression regulation due to their critic role in 
controlling mRNA metabolism and ncRNAs function. Supporting the importance of 
RNA-protein interactions in cellular homeostasis is the link between RBPs 
dysfunction and disease (Castello et al., 2013; Darnell, 2010a). 
RBPs functionality relies on their ability to selectively recognize and bind specific 
motives within target RNAs through an array of diverse RNA-binding domains 
(RBDs). RBDs are deeply conserved in bacteria, archaea and eukaryotes 
(Gerstberger et al., 2014), suggesting their contribution to essential biological 
processes across all kingdoms. Even if different RBDs adopt different strategies to 
bind RNA, some general features exist characterizing RBPs–RNA interactions.  
RNA recognition is driven by the overall protein fold (involving hydrogen bonds 
with backbone atoms) as well as by specific amino acid side chain–nucleotide 
interactions. In particular, two modes of binding can be distinguished, that is, groove 
or β-sheet binding. In the former case, a structured domain of the protein is 
positioned into the groove of an RNA helix, while in the latter one, binding pockets 
are formed on β-sheets surfaces, interacting with unpaired RNA bases (Jones et al., 
2001). Target specificity is often accomplished by way of hydrogen bonding and 
electrostatic interactions; binding affinity relies on electrostatic and stacking 
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interactions (Aviv et al., 2006; Jones et al., 2001).  
Individual RBDs usually contact a few nucleotides, and combinations of RBDs 
within the same protein are frequently observed, likely to increase affinity and 
specificity (Cook et al., 2015). Collectively, recognition of sequence as well as 
structural elements within the target RNAs may occur, according to the specific 
characteristics of different RBDs. Among the most well-characterized RBDs we list 
RNA recognition motives (RRM), K-homology (KH) domains (type I and type II), 
RGG (Arg-Gly-Gly) boxes, zinc fingers (ZnF, mostly C-x8-X-x5-X-x3-H), double 
stranded RNA-binding domains (dsRBD) and Pumilio/FBF (PUF or Pum-HD) 
domains (Cook et al., 2015). Features of the main canonical RBDs are summarized 
on Table 1. Of notice, not all RBPs contain canonical RBDs (Aviv et al., 2006; 
Battle and Doudna, 2001). 
 
 
Table 1. Characteristics of RNA-binding domains. Adapted from Lunde et al., 2007. 
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4.2 Methodologies to study RNA/protein interactions 
Recent technological developments have allowed characterization of RNA–protein 
interactions at an unprecedented scale. The methods currently employed can be 
broken down into two general categories: ‘protein-centric’ and ‘RNA-centric’. These 
alternative, but often complementary approaches allow to selectively focus on 
different aspects of RNA-protein interactions.  
“Protein-centric” approaches are usually chosen to identify consensus RNA-binding 
motives for RBPs or, more widely, to profile target RNAs of a desired known RBP. 
The most popular in vitro “protein-centric” approaches include SELEX (systematic 
evolution of ligands by exponential enrichment) (Ellington and Szostak, 1990; Tuerk 
and Gold, 1990) and its more recent combination with NGS SEQRS (Campbell et al., 
2012), RNAcompete (Ray et al., 2009) and RNA Bind-n-Seq (Lambert et al., 2014). 
Collectively, these methods allow the selection of preferred high-affinity RNA-
binding sites for specific RBPs, starting from randomized pools of RNAs. In vivo, 
“protein-centric” approaches generally rely on the ability to purify a protein (Hogan 
et al., 2008), or class of proteins (Ingolia et al., 2009), followed by sequencing of the 
associated RNAs. The first genome-wide analysis for characterization of RBP-RNA 
interactions involved immunoprecipitation of RBP–RNA complexes using antibodies 
against endogenous proteins or epitope tags followed by microarray analysis (RIP-
chip) (Tenenbaum et al., 2000) or high-throughput sequencing (RIP-seq).  
Improvements of such methods based on cross-linking the RBP to the RNA using 
UV radiation before immunoprecipitation (CLIP) ensures maintaining of in vivo 
contacts (Ule et al., 2003). In particular, coupling of CLIP to high-throughput 
sequencing (HITS-CLIP or CLIP-seq) enables genome-wide identification of RBPs 
binding sites (Darnell, 2010b; Hogan et al., 2008; Zhang and Darnell, 2011). Global 
data lead to the observation that RBP-to-mRNA interactions are, in general, many-to-
many, with each RBP interacting with diverse mRNAs, and each mRNA being 
regulated by several RBPs (Hogan et al., 2008). Moreover, such approaches provided 
initial insights into proteins interacting and regulating lncRNAs' action (Khalil et al., 
2009; Rinn et al., 2007; Zhao et al., 2008). 
  33 
As these approaches require knowledge of the protein, they are of more limited 
utility for defining the proteins that associate with a given RNA transcript. The 
advent of mass spectrometry (MS) resulted in the development of complementary 
genome-wide approaches to determine selected RNAs interactomes, as well as to 
discover new RBPs. In this context, “RNA-centric” methods rely on the capture of a 
given RNA, or class of RNAs, and identify the associated proteins by using MS 
(Baltz et al., 2012; Castello et al., 2012). Thus, hundreds of RBPs have been 
identified and validated, with a considerable portion of these lacking previous 
functional annotation as RBPs or containing non-canonical RBDs. Despite having 
great potential, MS-based approaches do not lack some major caveats. First, these 
procedures rely on complex multi-step protocols which need to be specifically 
optimized for different RNP complexes. Moreover, sensitivity limitations of MS may 
lead to underrepresentation of those complexes made-up of low abundant transcripts 
and/or RBPs (Castello et al., 2012) and, at the same time, to overrepresentation of 
proteins with low complexity sequences (Baltz et al., 2012). Some of these 
limitations could be overcome by approaches based on the screening of protein 
libraries, both in vivo (Harada et al., 1996; Koh and Wickens, 2014) and in vitro 
(Danner and Belasco, 2001; Laird-Offringa and Belasco, 1996; Siprashvili et al., 
2012). Any format of protein library can faithfully represent the complexity of a 
desired full-length proteome, either as an array of candidate proteins or as products 
of selected Open Reading Frame (ORF) libraries.  
In particular, most in vitro approaches are based on selection of RBPs or RBDs 
exposed to immobilized or labelled target RNAs. Usually, different rounds of 
selection and amplification of the progressively selected libraries are carried out.  
The main drawbacks related to in vitro selection of protein libraries may derive from 
limited accessibility of binding sites, lack of in vivo-supported post-translational 
modifications (and subsequent impossibility to isolate proteins that bind RNA by 
virtue of these), overrepresentation of certain clones within the starting library (and 
generation of false positives) and occasional failure in proper protein folding 
(DiDonato et al., 2004; Roberts and Szostak, 1997). However, some of these issues 
could be partially or completely overcome: for example, during their constructions, 
libraries can be “filtered”, thus exclusively displaying correctly folded, stable, active 
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proteins. If this is still a difficult task for full-length proteins, it is instead more easily 
achievable for protein domains. Indeed, small structurally-conserved protein domains 
can be independently expressed while still preserving their individual functions 
(Fields and Song, 1989; Heger and Holm, 2003). Thus, screening a library 
encompassing the entire collection, or mostly, of functional domains encoded by a 
genome (Domainome) could provide a simple method to annotate gene products, 
including those encoding RBPs. When combined with next generation sequencing 
(NGS), these “domainome” libraries can be used as universal screening tools for the 
most diverse purposes, including rapid interactome profiling (D’Angelo et al., 2013; 
Di Niro et al., 2010). Among the methodologies for in vitro selection of protein 
libraries, phage display has been successfully employed to identify protein partners 
of desired target RNAs (Laird-Offringa and Belasco, 1996; Patrucco et al., 2015).  
In vitro phage display selection to study RNA-protein interactions 
Phage display was created by G. Smith in 1985 (Smith, 1985) as a method for 
presenting polypeptides on the surface of lysogenic filamentous bacteriophages. 
Since then, this method has become one of the most effective ways for producing 
large amounts of peptides, proteins and antibodies. 
Even if traditionally employed to investigate protein-protein interactions, phage 
display has been successfully used to investigate RNA-protein interactions as well 
(Danner and Belasco, 2001; Laird-Offringa and Belasco, 1996). Recently, Patrucco 
and colleagues proposed a novel platform exploiting phage display technology to 
profile the interacting proteome of selected RNAs (Patrucco et al., 2015). The 
approach combines the selection of a phage library displaying "filtered" open ORFs 
with next-generation DNA sequencing. In particular, the pipeline was validated by 
using a well-characterized RNA/RBP pair and proved to be efficient in isolating both 
known and new RBPs specific for the target RNA.  
Phage display is based on a direct linkage between phage phenotype and its 
encapsulated genotype, which leads to presentation of molecule libraries on the 
phage surface. The gene encoding the displayed molecule is packed within the same 
virion as a single-strained DNA (ssDNA) and the displayed peptides or proteins are 
expressed in fusion with phage coat protein (Kaplan and Gershoni, 2012). This 
coupling between genotype and phenotype ensures that identical phage particles will 
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be obtained from the same infected Escherichia coli clone.  
The phage display technology has provided the ability to create protein libraries 
containing a great number of phage particles, encoding and displaying different 
molecules. Phage libraries can be used to investigate interactions with desired targets 
(proteins, RNA or DNA). Biopanning—the procedure of specific binders selection—
is essential for enriching the desired molecule level. The selection-driving target is 
immobilized on a solid support, incubated with the phages and repeated cycles of 
incubation, washing, amplification and re-selection of bound phages are carried out 
(Figure 10). 
 
 
Figure 10. The phage display cycle. Phages are amplified and exposed to a desired target. Bound 
phages are eluted and subsequently re-amplified for further rounds of selection. Unbound phages are 
eliminated by stringent washes. Modified from http://phages.org/phage-display/. 
Most phage libraries are built by taking advantage of phagemids. These are plasmids 
(4.6 kilobases) which encode a signal sequence, the phage coat protein and an 
antibiotic resistance marker. The fragment/polypeptide of interest is cloned upstream 
of the coat protein sequence and expression is controlled by the use of a promoter 
such as lacZ. A phagemid cannot produce infective phage particles alone, in fact, a 
helper phage is required, which provides the genes essential for phage replication and 
assembly, including a wild-type copy of the coat protein used for display (Carmen 
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and Jermutus, 2002).   
Application of ß-lactamase-based filtering to randomly fragmented DNA from 
diverse sources allows generation of phage libraries enriched for genic ORFs 
(D’Angelo et al., 2011; Di Niro et al., 2010; Zacchi et al., 2003). This relies on the 
assumption that only fragments of functional ORFs are likely able to form the 
foldable domains which do not affect the correct folding and activity of the fused ß-
lactamase reporter protein. Conversely, random ORFs do not fold into coherent 
domains and lead to aggregation, misfolding and inactivation of the reporter.  
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AIMS OF THE STUDY 
Although lncRNAs represent the major transcriptional output of mammalian cells, 
only a limited number of these have been associated with specific functions. AS 
Uchl1 and, more in general, SINEUPs constitute a family of natural AS lncRNAs 
enhancing translation of complementary target mRNAs. Two discrete domains are 
essential in SINEUPs: an overlapping region to a target mRNA or BD dictates target 
specificity, while an embedded inverted SINEB2 element or ED confers biological 
activity. Taken advantage of SINEUPs modular organization, artificial SINEUPs can 
be re-directed against desired mRNA by solely manipulating the BD. 
The domain architecture of SINEUPs support the model of lncRNAs working as 
flexible modular scaffolds, with each functional unit being independently capable of 
recruiting different molecular effectors. However, if the role attributed to the BD is 
to “guide” and mediate SINEUPs interactions with target mRNAs, the mechanisms 
determining the biological activity of the inverted SINEB2 as SINEUPs ED remain 
unclear. SINEB2 elements present a highly conserved secondary structure, deriving 
from the RNA molecules from which they emerged (tRNAs). Interestingly, in most 
lncRNAs a strict link between structure and function has been demonstrated, and 
often the presence of structural motifs is required for engaging molecular partners 
modulating lncRNAs biological activity. 
In this context, in first place we investigated the molecular mechanisms regulating 
SINEUPs activity by focusing on:  
1) the structural basis for activation of protein synthesis mediated by SINEUPs ED in 
natural and synthetic SINEUPs 
2) the identification of SINEUPs protein partners. 
As further long-term goal, to asses SINEUPs scalability for potential applications in 
biotechnology as well as in therapy, we aimed at: 
3) validating SINEUPs as RNA tools to increase protein synthesis. 
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MATERIALS AND METHODS 
Constructs 
Plasmids expressing AS GFP, AS Uchl1, AS Uchl1 ΔB2, AS Uchl1 ΔAlu and AS 
Uchl1 ΔTE (previously referred to as ΔTOT) were previously described (Carrieri et 
al., 2012). PcDNA3.1- (Thermo Fisher Scientific) and pEGFP-C2 (Clontech) were 
commercially available vectors. 
AS Uchl1 mutant lacking the SL1 domain within the invSINEB2 element (Δ68-77 
nt) was obtained by gene synthesis and cloned between XbaI/HindIII sites in pcDNA 
3.1(-).  
AS GFP was used to create AS GFP ΔSL1 mutant. Mutagenesis PCR primers were 
designed by QuikChange Primer Design Program (Agilent). 
For the bacterial expression of GST-fusion products, ORF fragments were excised 
with BssHII-NheI from the phagemid DNA and subcloned into a custom-designed 
pGEX-FLAG expression vector as previously described (Heger and Holm, 2003). 
The vector contains a FLAG-tag (DYKDDDDK) for C-terminal tagging of expressed 
proteins.  
Biopanning procedures 
For biopanning experiments, phage particles were resuspended in PBS buffer at a 
concentration of 1011 cfu/µl and for each selection 1012 phages were used. Production 
and rescue of phagemids were carried out according to published protocols 
(D’Angelo et al., 2013). The ORF phage library used in this study has been described 
previously (Di Donato et al., 2004).  
Selections were driven by two SINEUP-related baits: i) AS Uchl1 ∆5’ and ii) 
inverted SINEB2 from AS Uchl1. These were transcribed in vitro (IVT) with 
commercially available kits (MEGAscript® T7 Kit Ambion for AS Uchl1 ∆5’and 
MEGAshortscript™ T7 Transcription Kit for the inverted SINEB2), using original 
plasmids as template (Carrieri et al., 2012). IVT RNAs were 3' biotinylated using 
Pierce RNA 3’ End Biotinylation kit (Thermo Fisher Scientific).  
Pre-clearing of phages was performed prior to start with selection: 20 ul of 
streptavidin-coated magnetic beads (New England Biolabs) were washed in TENT 
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buffer (10 mM Tris HCl pH 8.0, 1 mM EDTA, 250 mM NaCl, 0,5% triton X-100) 
and incubated with 1012 phages in TENT buffer for 30’ at room temperature. This 
step significantly reduced the presence of “sticky” phages binding to beads or 
plastics.  Unbound phages were recovered and employed for selection.  
Selections were carried out as follows: 3 pmoles of IVT RNA bait were diluted in 
TENT buffer implemented with RNAse inhibitors (SUPERase In™ RNase 
Inhibitors, Thermo Fisher Scientific) and incubated with pre-washed streptavidin 
magnetic beads for 20’ at room temperature and subsequently washed. Pre-cleared 
phages were then added and left for 45’ at room temperature, in the presence of 
competitors. In particular, for each bait we carried out two parallel selection 
protocols, different in the competitor used (1 ug/ul tRNAs from E. coli, SIGMA 
ALDRICH or ssDNA oligos from herring sperm). Complexes were extensively 
washed, to get rid of unbound phages. RNA-binding phages were finally eluted in the 
presence of RNAse A (10 ug/ml in 10 mM Tris pH 8.0, 1 mM EDTA, 15 mM NaCl, 
2’ treatment at room temperature).  These were used for infection of E. Coli DH5α at 
OD600 0.5 at 37°C for 45’, thus giving rise to one selected library specific for each 
RNA bait. The selected phage pool was amplified in E. coli DH5α and the 
biopanning procedure was repeated for a second round. Higher stringency was 
achieved by increasing the number of washing steps. Two consecutive selection 
cycles previously proved to be efficient in screening out without introducing 
significant restrictions in output diversity (Fan and Steitz, 1998). After the second 
round of selection, colonies growing on agar plates were harvested and plasmid DNA 
was isolated by standard miniprep procedure.  
NGS and bioinformatic analysis 
CDNA inserts were PCR-amplified with barcoded Molecular Identifier (MID) 
tagged–primers (MID-primers) and sequenced by Illumina SMARTSeq platform. 
Bioinformatic analysis were performed with NGS-Transcriptome profile explorer 
(Trex) system (Boria et al., 2013). Sequences were mapped onto the human genome 
(NCBI build 36) and matching sequences were compared with annotated genes.  
Rescue of phagemid clones by inverse PCR 
Rescue of phagemid clones was performed as described previously (Patrucco et al., 
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2015a). Briefly, a pair of specific back-to-back outward primers was design for each 
of the tested genes, centering on the nucleotide region identified by the overlapping 
reads. PCR was performed with a Phusion High-Fidelity DNA Polymerase (Thermo 
Scientific). PCR products were gel purified, phosphorylated with T4 polynucleotide 
kinase, ligated by T4 DNA ligase and transformed. Colonies growing on ampicillin 
plates were randomly picked and grown into 1ml 2X TY medium. 
GST-fusion proteins expression and purification 
ORF fragments subcloned in pGEX-FLAG were transformed into E.Coli BL21 
(DE3) cells. Bacterial cultures (100 ml) were grown at 28°C until OD600 = 0.5, 
induced with 1 mM IPTG for 3 hours and centrifuged. Bacterial pellets were 
resuspended in lysis buffer (PBS containing 1% Triton X-100, 200 µg/ml lysozyme, 
20 µg/ml DNAse, protease inhibitors, Roche), incubated for 30’ at 4°C and sonicated 
for 2-3 minutes. Cell debris were removed by centrifugation and supernatants 
combined with glutathione-agarose beads (Sigma-Aldrich) for 1h at 4°C under gentle 
rotation. After three washes in PBS-Tween 0.1% followed by three more in PBS, 
GST fusion proteins were eluted in 750 ul elution buffer (50 mM reduced 
glutathione, 100 mM NaCl, pH 8.0). Proteins were dialyzed against PBS and 
checked for purity and concentration by SDS-PAGE. Quantitative densitometry of 
Coomassie Blue-stained proteins was calculated with ImageJ software (Shu et al., 
2006) using BSA as reference for protein quantification. GST-fusion proteins 
integrity was determined by western blotting, using two different monoclonal 
antibodies: anti-GST (clone GST-2, Sigma-Aldrich) and anti-FLAG (Sigma-
Aldrich). 
ELISA 
Screening of selected clones in ELISA-based assays, either in the phage format or as 
soluble GST-fusion polypeptides, was performed according to standard protocols 
described previously (Danner and Belasco, 2001), with some modifications. Briefly, 
phage ELISA was performed with Microlon plates (Greiner) coated overnight at 4°C 
with 10 μg/ml streptavidin. After blocking and rinsing wells in TENT buffer, 
biotinylated RNA oligonucleotides (5 pmoles/well, diluted in 100 µl TENT buffer 
implemented with RNAse inhibitors) were captured on the plates. Phage-containing 
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supernatants of individual clones, diluted 1:1 in TENT buffer with RNAse inhibitors, 
were added to the wells and incubated for 45’. Following three washing steps, 
incubation with HRP-conjugated anti-M13 monoclonal antibody (GE Healthcare) for 
1 hour at room temperature was carried out. Signal was revealed with TMB (3, 3’, 5, 
5’ tetramethylbenzidine) and read at A450 using a VictorTM X4 multilabel plate reader 
(Perkin Elmer). ELISA on soluble GST-fusion polypeptides was performed as 
described above. In particular, baits-coated wells were subsequently incubated 1 hour 
at room temperature with the purified proteins, extensively washed in TENT buffer 
and again incubated 1 hour with a mouse monoclonal anti-GST antibody (clone 
GST-2, Sigma-Aldrich) 1:5000 in TENT buffer. Following 1 hour incubation with a 
HRP-conjugated secondary antibody (Sigma-Aldrich), signal coming from RNA-
protein binding was revealed as described above. 
Cell culture and transfection 
Neuro2a cells were obtained from ATCC (Cat. No. ATCC-CCL-131) and maintained 
in culture with Minimum Essential Medium Earle’s Salt + GlutaMAX™-I (MEM, 
Gibco by Life Technologies, Cat. No. 41090-028) supplemented with 10% FBS 
(Sigma) and 1% antibiotics (penicillin/streptomycin), as suggested by the vendor. 
HEK 293T/17 cells were obtained from ATCC (Cat. No. ATCC-CRL-11268) and 
maintained in culture with Dulbecco's Modified Minimum Essential Medium 
(DMEM, Gibco) supplemented with 10% FBS (Sigma) and 1% antibiotics 
(penicillin/streptomycin), as suggested by the vendor. MN9D cells were obtained 
from prof. Michael Zigmond at University of Pittsburgh and maintained in culture 
with Dulbecco's Modified Minimum Essential Medium (DMEM, Gibco) 
supplemented with 10% FBS (Sigma) and 1% antibiotics (penicillin/streptomycin). 
For structure/function validation experiments, Neuro2a and HEK 293T/17 cells were 
plated in 6 well-plates the day before transfection at 50% confluency and transfected 
with AS Uchl1 or AS GFP plasmids, respectively, using Lipofectamine® 2000 (Life 
Technologies™) and following manufacturer’s instructions.  
For RNA immunoprecipitation (RNA-IP) experiments, 2.5X 10^6 HEK 293T/17 
were plated in 10 cm plates and transfected after 16-20 hours with AS Uchl1 plasmid 
using FuGENE® HD Transfection Reagent (Promega), following manufacturer’s 
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instructions.  Data of RNA and protein were obtained from the same transfection in 
each replica.  
For nucleocytoplasmic fractionation experiments in HEK 293T/17, 4X10^5 cells 
were plated in 6-well multiwell and transfected after 16-20 hours with AS Uchl1, AS 
Uchl1 ΔB2, AS Uchl1 ΔAlu or AS Uchl1 ΔTE, following Fugene HD 
manufacturer’s instructions. For nucleocytoplasmic fractionation experiments in 
N2A and MN9D, 3X10^6 cells were plated in 100-mm dishes and transfected after 
16-20 hours with AS Uchl1, using Lipofectamine® 2000 (Life Technologies™) and 
following manufacturer’s instructions.  
RNA-IP  
All the stock solutions were prepared with clean and pure reagents diluted in 
DEPC/Ambion water (AM9932, Ambion™), using RNAse-free equipment. Lysis 
and washing buffers were freshly-prepared and kept on ice; all steps, including 
centrifugation, were performed at 4°C.  
In vivo formaldehyde fixation 
At 48 hours post-transfection cells were washed once in ice-cold PBS, scraped and 
subsequently washed twice in 10 ml of cold PBS (3000 rpm, time: 4’). Cells were 
fixed in 1% formaldehyde (AR grade, Mallinkrodt) in PBS for 10’ at room 
temperature with slow mixing and quenched in 0.25 M glycine (pH 7) at room 
temperature for 5’. Cells were subsequently harvested by centrifugation at 3000 rpm 
for 4’ and washed twice with ice-cold PBS.  
Beads blocking and coating 
100 ul of M-280 Sheep anti-Mouse dynabeads (Life Technologies) were washed 3 
times in washing buffer (0.1% BSA in PBS), blocked with 3 washes in 0.5% BSA in 
PBS and finally washed twice in RIP buffer (25 mM Tris-HCl pH 7.4, 150 mM KCl, 
0.5% IGEPAL CA-630, 5 mM MgCl2, 0.5 mM DTT, protease inhibitors and 20 
U/ml Superase RNA inhibitors). Coating with antibody/control IgG was carried out 
by overnight incubation of blocked beads with 20 ug of anti-DRBP76 (BD Science) 
or 20 ug of normal mouse IgG (Sigma-Aldrich) in a final volume of 180 ul.  
Lysis and IP  
Lysis was performed using 1 ml RIP buffer. Lysates were solubilized by sonication 
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with two short pulses (15 sec). Between the two cycles samples were kept on ice for 
at least 2’. Insoluble material was removed by centrifugation at 13,000 rpm for 10’. 
Total lysate was pre-cleared via incubation with 100 ul of uncoated blocked beads 
for 30’ at 4°C with gentle rotation. After recovering from beads, the lysate was split 
and incubated with specific antibody or control IgG-coated beads overnight on a 
rotary platform at 4°C. 1/20 of total pre-cleared lysate was kept before splitting as 
INPUT.  
Washing steps 
Beads/Ab/lysate complexes were washed six times (5' the first and last wash/ 1' the 
remaining ones) in RIP washing buffer (same as RIP buffer, but with 300 mM KCl) 
in a cold room.  
Reversal of cross-linking and elution 
For reversal of cross-linking and elution, beads containing the IP samples were 
resuspended in 100 ul of elution buffer (50 mM Tris-Cl pH 7.0, 5 mM EDTA, 10 
mM DTT and 1% SDS) and incubated at 70°C for 45’. Supernatants were recovered 
and resuspended in 1 ml of Trizol (Ambion™/Life Technologies) and both RNA and 
proteins were extracted according to the manufacturer’s instructions. 
RNA isolation, reverse transcription and quantitative Real Time-PCR (qRT-
PCR) 
RNA was extracted using TRIZOL reagent (Ambion™/Life Technologies), 
following manufacturer’s instructions. RNA was eluted and treated with TURBO 
DNA-free Kit (Ambion) for 15' at 37°C, to avoid plasmid DNA contamination. RNA 
quality was finally checked on a formaldehyde agarose gel.  
cDNA was prepared from 250 ng of purified RNA using iSCRIPTTM cDNA 
Synthesis Kit (Bio-Rad), according to manufacturer’s instructions. In particular, for 
RNA-IP experiments, equal volumes of DNAse-treated RNA samples were used for 
reverse transcription.  
In order to monitor the efficiency of DNAse treatment, an equal amount of each 
RNA sample was retrotranscribed in the absence of RT.  
qRT-PCR reaction was performed on diluted cDNA (1:2.5) using SYBR-Green PCR 
Master Mix (Biorad) and an iCycler IQ Real time PCR System (Bio-Rad). In 
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particular, in RNA-IP experiments, undiluted cDNA was used as qRT-PCR input.  
Oligonucleotide sequences of primers used in this study for GAPDH, beta-actin, 
Uchl1, GFP, AS Uchl1 (primers 5') and AS Uchl1 (primers 3', used for detection of 
AS GFP) were previously described (Carrieri et al., 2012). Primers used for detection 
of UBC were previously described (Kuwano et al., 2008). Primers used for detection 
of precursor-rRNA (pre-RNA) were previously described (Murayama et al., 2008; 
Oie et al., 2014). 
The amplified transcripts were quantified using the comparative Ct method and 
relative gene expression was calculated with the ΔΔCt method (Schmittgen and 
Livak, 2008). 
Western Blot 
For Western Blot (WB) analysis, cell pellets were directly dissolved in Laemmli 
sample buffer. For RNA-IP experiments in particular, ILF3 IP efficiency was 
monitored by loading the whole fraction of proteins recovered from the organic 
phase after Trizol extraction, resuspended in Laemmli sample buffer. All lysates 
were briefly sonicated, boiled and loaded on 10% (for ILF3) or 12% (for UCHL1 and 
GFP) poly-acrylamide gels.  Immunoblotting was performed with the following 
primary antibodies: anti-UCHL1 (Millipore, Cat. No. AB1761-I) 1:5000; anti-GFP 
(Living Colours), 1:8000; anti-DRBP76 (BD Science), 1:500 overnight; anti-β-actin 
(SIGMA ALDRICH) 1:2000; anti-NONO (SIGMA ALDRICH), 1:500. Signals were 
revealed after incubation with horseradish peroxidase-conjugated (HRP) secondary 
antibodies (DakoCytomation, Glostrup, Denmark) 1:1000 or anti-protein A HRP 
(Sigma-Aldrich) for 1 hour at RT, in combination with ECL (GE Healthcare, Cat. 
No. RPN2105). Image detection was performed with Alliance LD2-77WL system 
(Uvitec, Cambridge).  
Cell fractionation 
Nucleocytoplasmic fractionation was performed as previously described (Wang et 
al., 2006). Cell handling and centrifugation steps were done at 4°C; all buffers were 
kept on ice.  
Briefly, at 48 hours post-transfection cells were washed in ice-cold PBS, scraped on 
ice and collected in 1.5 ml eppendorf tubes. A fraction (usually 1/10) of cells was 
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kept for total lysate analysis. Cells were harvested by centrifugation (3', 4000) at 
4°C, washed twice in PBS and resuspended in 1 ml of RSB (10 mM Tris, pH 7.4, 10 
mM NaCl, 3 mM MgCl2). Lysates were incubated 3’ on ice and subsequently 
centrifuged at 4000 rpm for 3' at 4 °C. 
Supernatants were discarded and cell pellets resuspended in a volume of RSBG40 
(10 mM Tris, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 10% glycerol, 0.5% Nonidet P-
40, 0.5 mM dithiothreitol -DTT, and 10 U/ml SUPERase) equal to 4X pellet volume, 
by slow pipetting. Nuclei were pelletted at 7000 rpm for 3’ and supernatants 
recovered and saved as the first (soluble) cytoplasmic fraction. Nuclear pellets were 
again resuspended in RSBG40 implemented with 1/10 volume of detergent (3.3%-
wt/wt sodium deoxycholate and 6.6%-vol/vol Tween 40) and incubated on ice for 5’. 
Following centrifugation (3', 7000 rpm) supernatant (insoluble cytoplasmic fraction) 
was pooled with the previous, whereas pellets were washed three times more in 1 ml 
of RSBG40 and finally spinned at 10,000 rpm for 5’. The resulting pellet 
corresponded to nuclear RNA fraction. RNA samples were resuspended in 1 ml of 
Trizol (Invitrogen) and RNA isolated using following manufacturer’s instruction. 
RNA was eluted and treated with Turbo DNAse (Ambion). The purity of fractions 
was confirmed by qRT-PCR on pre-ribosomal RNA and GAPDH. 
ILF3 silencing 
4X10^5 HEK 293T/17 were harvested on a 6-well multiwell and co-transfected with 
4 ug of AS Uchl1 plasmid and 4 ug of ILF3 siRNA (Mission esiRNA, mouse ILF3, 
SIGMA ALDRICH)/control siRNA (All Stars Neg. Control siRNA, Qiagen) with 10 
ul of Lipofectamine® 2000 (Life Technologies™) in serum-free DMEM with no 
antibiotics. After 24h, a second round of transfection was performed, using 2 ug of 
both plasmid and siRNA. On the following day medium was changed with 10% 
FBS-DMEM. At 48h from the second transfection cells were collected for 
fractionation. 1/20 of total cells were resuspended in Laemmli sample buffer for WB 
analysis of ILF3 protein levels in silenced/control cells.  Nucleocytoplasmic 
fractionation was performed as described before and cell fractions resuspended in 1 
ml of Trizol. 
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ILF3/p54nrb co-immunoprecipiation (co-IP) 
ILF3 IP was performed as described above (section: RNA-IP). The presence of 
p54nrb in IP complexes was revealed with anti-NONO antibody (SIGMA) prior to 
detect ILF3, on the same nitrocellulose membrane. 
Immunofluorescence microscopy 
Cells were fixed in 4% paraformaldehyde in PBS for 10’ at room temperature, 
washed twice in PBS and treated with glycine 0.1 M in PBS for 5' at room 
temperature. Following two more washes in PBS, fixed cells were permeabilized 
with 0.1% Triton X-100 for 4' at room temperature and blocked with 0.2% BSA, 1% 
FBS, and 0.1% Triton in PBS for 5’ at room temperature. Cells were incubated 90' 
with  anti-DRBP76 (BD Bioscience) 1:50  in blocking solution at room temperature, 
washed in PBS three times and finally stained with Alexa Fluor-488 or Alexa Fluor-
594 (Invitrogen)-labelled anti-mouse or anti-rabbit secondary antibodies, 1:250 in 
blocking buffer. Nuclei were visualized with DAPI (1 ug/ml). Homemade anti-DJ-1 
1:250 (Foti et al., 2010) or anti-thyrosin hydroxylase (TH) (Chemicon) 1:1000 were 
used to counterstain cell cytoplasm. Images were captured with a confocal 
microscope (LEICA TCS SP2). 
Statistical analysis 
All data are expressed as mean ± standard deviation on n≥3 replicas. Statistical 
analysis was performed using Excel software. Statistically significant differences 
were assessed by Student’s t-test. Differences with p<0.05 were considered 
significant. 
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UNPUBLISHED DATA OF PROFESSOR S. GUSTINCICH 
LABORATORY IN COLLABORATION WITH PROFESSOR J. 
PLAVEC LABORATORY  
Secondary structure of the inverted SINEB2 embedded in AS Uchl1 RNA 
The secondary structure of the inverted SINEB2 element (invSINEB2/183) contained 
in AS Uchl1 was determined using chemical footprinting. The RNA was in vitro 
transcribed from a plasmid containing the invSINEB2 sequence of AS Uchl1. DMS 
(dimethyl sulfate) and CMCT (1-cyclohexyl-(2-morpholinoethyl) carbodiimide 
metho-p-toluene sulfonate) were used as methylating agents. DMS preferentially 
methylates positions N1 and N3 of adenines and cytosines, respectively, while 
CMCT methylates position N3 of uridines and to a lesser extent N1 of guanines. The 
level of methylation is directly related to the accessibility to solvent of potential 
modification sites. Therefore, hydrogen bonded nucleotides are not methylated, 
while non-hydrogen bonded are. The methylation sites were analyzed by reverse 
transcribing RNA into cDNA starting from a fluorescently labelled DNA primer. The 
DNA oligos were analyzed on large sequencing gels and visualized on a 
densitometer. Data from footprinting studies has been used as an input for restrained 
mFOLD secondary structure prediction. It is noteworthy that data from either of the 
chemicals was sufficient for an unambiguous secondary structure determination. The 
invSINEB2/183 RNA folds into a structure with mostly helical secondary structure 
elements (Figure 11).  
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Figure 11. Secondary structure of the inverted SINEB2/183 ED of AS Uchl1. tDMS and CMCT 
reactive nucleotides are shaded in blue and red, respectively. Internal loops and stem-loops are 
labelled as ILx and SLx, respectively. Non-reactive nucleotides are only circled. The segment shaded 
in gray corresponds to the DNA primer hybridization site.  
The structure exhibits several bulges, asymmetric internal loops and hairpins. 
Consisting of nucleotides 5-8 and 167-172, the internal loop (IL1) could not be 
directly probed with DMS or CMCT due to hybridization of the fluorescent DNA 
primer to the 3' of the RNA. This internal loop is followed by a helical region, which 
contains three single nucleotide bulges, with nucleotides G154, A157 and U160 
showing weak reactivity with methylating agents. The asymmetric internal loop 
(IL2) is comprised of nucleotides 23-25 and 144-149. Data suggests that G26:U144 
base pair is not formed according to chemical footprinting as U144 is reactive with 
CMCT, while U143 remains protected. This is to be expected, due to the relatively 
low stability of GU base pairs, especially at the termini of helical regions.  
The invSINEB2/183 construct features two more internal loops, which branch out 
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into short hairpins. Comprised of nucleotides 37-41 and 123-132, the internal loop 
(IL3) is branched into a short stem-tetraloop element (SL3). Similarly, nucleotides 
53-63 and 93-111 form a larger internal loop (IL4) with a stem-heptaloop motif 
(SL2). The terminal hairpin (SL1) includes nucleotides 64-92 and exhibits a G/C rich 
stem with an A/U rich loop region. All stem nucleotides up to C64 and G92 are 
protected from methylation, including U66:U90 mismatch nucleotides. On the other 
hand, loop nucleotides G77, U78 and G79 are all susceptible to methylation by 
CMCT. Importantly, U80 can be methylated by DMS while U81 exhibits very weak 
reactivity. Partial solvent access suggests that the two A:U base pairs are involved in 
an equilibrium between opened and closed states. 
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RESULTS  
1 Structural basis for activation of protein synthesis mediated by the ED in 
natural and synthetic SINEUPs 
1.1 The terminal SL1 hairpin contributes to AS Uchl1 ability to increase 
UCHL1 protein levels 
As previously introduced, the embedded invSINEB2 element acts as ED in natural 
SINEUP AS Uchl1. Deletion of invSINEB2 sequence, but not of the embedded Alu 
repeat, abolishes UCHL1 protein up-regulation mediated by AS Uchl1 in mouse 
neuroblastoma cell lines (Carrieri et al., 2012). We investigated whether secondary 
structure components of invSINEB2 affect the function of AS Uchl1 RNA. We 
focused our attention on the terminal SL1 as, according to chemical footprinting 
data, it is the most stable secondary structure element within invSINEB2. The 
terminal stem-loop hairpin structure was thus disrupted by deleting nucleotides 68-77 
of invSINEB2 (ΔSL1) from full length AS Uchl1 (ΔSL1 mutant). This deletion 
would not affect the other helical regions. To investigate invSINEB2-ΔSL1 activity 
when embedded in full length AS Uchl1, we took advantage of murine 
neuroblastoma Neuro2a cells, as they express Uchl1 mRNA but do not contain 
detectable levels of endogenous wild type (WT) AS Uchl1. AS Uchl1 activity was 
defined as UCHL1 protein increase in the presence of unchanged mRNA levels, as 
quantified by western blotting and qRT-PCR, respectively (Figure 12). AS Uchl1 
WT was able to increase UCHL1 protein levels while maintaining stable Uchl1 
mRNA levels, as expected for a post-transcriptional regulatory mechanism. 
Conversely, ΔSL1 deletion mutant abolished the ability of AS Uchl1 RNA to up-
regulate UCHL1 protein levels. Indeed, UCHL1 amounts were comparable in cells 
transfected with ΔSL1 mutant and in control samples. 
Taken together, these data indicate that the terminal SL1 hairpin of embedded 
invSINEB2 is a structural determinant required for AS Uchl1 ability to increase 
protein levels as synthesized from its target mRNA. 
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Figure 12. The SL1 hairpin contributes to AS Uchl1 activity. Murine neuroblastoma N2a cells 
were transfected with AS Uchl1 and ΔSL1 mutant constructs. Control cells were transfected with an 
empty control plasmid. 48 hours after transfection, cells were lysed and processed for protein and 
RNA analysis. (A) Western blot was performed with anti-UCHL1 antibody. β-actin was used as 
loading control. (B) Expression of Uchl1 mRNA (gray bars) and AS Uchl1 (white bars) were 
monitored by qRT-PCR using specific primers. Data indicate mean ± st. dev. Data are representative 
of N=5 independent replicas.  
1.2 Conservation of the structural basis for activation of protein translation in 
synthetic SINEUPs 
A synthetic SINEUP against EGFP, named AS GFP, was generated previously 
(Carrieri et al., 2012). AS GFP is able to increase GFP protein translation when 
double transfected with corresponding S GFP DNA in HEK 293T cells (Carrieri et 
al., 2012). As in natural SINEUPs, the ability to enhance protein synthesis relies on 
the embedded inverted SINEB2 element. Following the identification of the SL1 as 
structural determinant for the ED-mediated translation activation in natural SINEUP 
AS Uchl1, we assessed whether similar regions of structural stability are involved in 
the activity of synthetic SINEUPs as well. To this purpose, we generated an AS GFP 
ΔSL1 mutant and tested its ability to modulate GFP translation in HEK 293T/17 
cells. Cells were co-transfected with S GFP and canonical or mutated AS GFP. As 
negative control, GFP was co-transfected with an empty vector. At 48 hours post-
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transfection cells were collected for protein and RNA analysis. Conversely to 
canonical AS GFP, which successfully enhanced GFP protein production, AS GFP 
ΔSL1 mutant failed in up-regulating GFP translation (Figure 13). 
 
 
Figure 13. The SL1 is a structural determinant for synthetic SINEUPs activity. HEK 293T/17 
cells were co-transfected with pEGFP and AS GFP or AS GFP ΔSL1 plasmids. Control cells received 
an empty control plasmid. 48 hours after transfection, cells were lysed and processed for protein and 
RNA analysis. (A) Western blot was performed with anti-GFP antibody. β-actin was used as loading 
control. (B) Expression of GFP mRNA (gray bars) and AS GFP (white bars) were monitored by qRT-
PCR using specific primers. Data indicate mean ± st. dev. Data are representative of N=3 independent 
replicas. 
Stable GFP mRNA levels in control, canonical and mutated AS GFP-transfected 
samples excluded that differences in protein quantity could be a consequence of 
different transfection efficiency. Taken together, these results suggest that the 
structural-based SL1 domain within inverted SINEB2 element is essential to 
maintain the ED activity in synthetic SINEUPs as well. 
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2 Identification of SINEUPs protein partners 
2.1 Identification of proteins that bind SINEUPs ED through ORF phage 
display selection 
Once defined the structure of the inverted SINEB2, as well as the presence of highly-
stable structural determinants involved in the activation of protein synthesis, we 
found intriguing to search for proteins binding and regulating the activity of 
SINEUPs ED. Indeed, many RBPs recognize specific structural motifs, like stem-
loops or bulges, within RNA molecules.  
To this purpose, we employed a high-throughput protein expression and interaction 
analysis platform aimed at identifying the RNA-Interacting Domainome (RIDome). 
The approach combines the selection of a phage library displaying “filtered” ORFs 
and NGS (Di Niro et al., 2010; Patrucco et al., 2015). 
The typical outcome is a list of ranked genes that directs analysis and validations to 
the best candidates. High-scoring ORFs are recloned from the library by inverse 
PCR, and their interactions are confirmed by ELISA-based assays. The interacting 
partners are then validated by RNA-IP and other functional assays.  
The library selection was performed as reported previously (Patrucco et al., 2015), 
with minor modification regarding the synthesis of the RNA baits which were 
generated by in vitro transcription (IVT) from a DNA template and then 
enzymatically biotinylated at the 3’ end (see Materials and Methods). All constructs 
employed in screenings and validation experiments are schematized in Figure 14. A 
summary of the RIDome pipeline is reported in Figure 15.  
  54 
 
Figure 14. Constructs used for selection and validation experiments. All constructs derive from 
AS Uchl1 wild type (WT). AS Uchl1 WT contains the BD (green), the ED or inverted SINEB2 (red) 
and the Alu (blue). AS Uchl1 Δ5’ lacks the 5’ end, including the BD. The inverted SINEB2 is from 
AS Uchl1. AS Uchl1 ΔSINEB2 lacks the ED. AS Uchl1 ΔTE lacks both SINEB2 and Alu. 
Abbreviations: BD=binding domain; ED=effector domain; TE=Transposable Elements. 
To explore the contribution of the ED in protein binding irrespective of its 
collocation within an AS lncRNA, we employed an IVT inverted SINEB2 as phage 
display selection-driving bait (Figure 15, first square). In parallel, we carried out a 
wider investigation of SINEUP-binding proteins by selecting the library on an IVT 
AS Uchl1 Δ5’. Lacking the BD, in which target specificity of different SINEUPs is 
encoded, AS Uchl1 Δ5’ provides the common backbone on which synthetic 
SINEUPs are built and includes the ED in an embedded format (Carrieri et al., 2012).  
In particular, we carried out two parallel selections for each bait, differing for the 
competitor used (tRNA or ssDNA). 
After two cycles of selection, phagemid DNAs were recovered, ORF inserts 
amplified and sequenced according to an Illumina SMARTSeq protocol. To limit the 
time-consuming analysis of large amounts of data, we decided to sequence a minimal 
fraction of the selection output, sufficient to contain an overview of the most likely 
repertoire of SINEUP-interacting ORFs. 
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Figure 15. SINEUP-driven phage display selection. First square: schematic representation of a 
SINEUP and its target mRNA. The red square highlights the region where the baits are contained in 
SINEUPs. The inverted SINEB2 and AS Uchl1 Δ5' were used as selection-driving baits. Baits were 
biotinylated at their 3' end. Second square: schematic representation of the selection protocol. 
Screenings were carried out by taking advantage of a “filtered” Open Reading Frames (ORF) phage 
library displaying human protein domains. Biotinylated baits were captured by streptavidin-binding 
magnetic beads and incubated with amplified phage library in the presence of tRNA/ssDNA 
competitor. Stringency washes allowed selective isolation of phages involved in bait-binding. Third 
square: after two cycles of selection, selection outputs were sequenced according to Illumina 
SMARTSeq protocol and sequencing results analyzed with T-Rex NGS software. Fourth square: high-
scoring ORF domains were cloned by inverse PCR and binding with target baits validated in vitro 
(ELISA) and in vivo (RNA-IP) (forth square). Abbreviations: BD=binding domain; ED=effector 
domain; CDS=coding sequence; RNA-IP=RNA immunoprecipitation. 
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2.2 NGS data analysis revealed ILF3 as the dominant candidate interactor 
We collected around 100.000 reads from each selected library that were analysed 
with the NGS-Trex system (Boria et al., 2013) and mapped onto the human genome 
(NCBI build 36). Sequences matching annotated genes were then ranked as 
described (Di Niro et al., 2010).  
As expected, the outcome of phage selections consisted of lists containing several 
hundreds of genes, most of them represented by very few reads and that form the 
“noise” of the phage selection. To remove most of such background, we arbitrarily 
set a threshold, and considered in successive analysis only those genes that were 
represented by at least 20 reads in the selected libraries and by at least four reads in 
the non-selected (NS) library (Table 2).  
 
Table 2. Summary of NGS results. For each selection the total number of reads, the mapping reads 
and their average length are reported. The number of selected genes is shown as well. Arbitrary 
parameters were applied to narrow the number of selected genes. Threshold was fixed to ≥ 4 and ≥ 20 
for unselected and selected libraries, respectively. 
This restriction allowed us to limit the analysis to few hundreds genes in total. 
Enrichment analysis was performed to assess those genes that were positively 
selected after biopanning experiments and calculated by dividing the normalized 
number of reads (reads per million, RPKM) in the selected libraries vs the NS 
library. Each gene was then plotted on a dispersion graph showing the fold 
enrichment vs the total number of reads. Results from each selection are shown in 
Figure 16. Comparing the four selections, it became evident that a single gene was 
strongly enriched during phage selection. In fact, unlike most genes included in the 
analysis which showed a fold enrichment in the range 2-20 fold, the interleukin 
enhancer-binding factor 3 (ILF3) was enriched by >1000 times in 3/4 selections.  
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Figure 16. Summary of NGS analysis. Results from inverted SINEB2 and AS Uchl1 Δ5’selections 
are shown. Selections in A were carried out with single-stranded DNA competitor; in selections 
represented in B tRNA was employed. Enrichment analysis were performed by dividing the 
normalized number of reads (reads per million, RPKM) in the selected libraries vs the non-selected 
library. Genes were plotted on a dispersion graph showing the fold enrichment vs the total number of 
reads. The blue circles correspond to enlarged areas in each chart. 
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We then compared the gene lists from the four selections. The Venn diagram 
depicted in Figure 17 shows that 18 genes are common to all four selected libraries, 
and 21 more genes are present in at least three samples. 
 
 
Figure 17. Comparison of enriched genes in different selections. The Venn diagram illustrates 
genes specifically enriched in each selection (outer area) or commonly identified in two or more 
selections (inner area). Blue= inverted SINEB2_tRNA; red=inverted SINEB2 ssDNA; orange=AS 
Uchl1 Δ5’_tRNA; green=AS Uchl1 Δ5’_ssDNA. 
2.3 In vitro validation of selected ORFs 
As a first general round of validation, we were interested in assessing whether the 
differential enrichment between ILF3 and the large majority of selected ORFs 
corresponded to differential binding specificity. To this purpose, together with ILF3, 
we selected a couple of clones showing lower fold enrichment (in the range of 20). In 
particular, we chose two well characterized RBPs, HNRNPA3 and SRSF5. 
HNRNPA3 was present in all selections, while SRSF5 was found in 3/4 (Appendix 
Table 1 and Table 2). Thus, corresponding clones were recovered from selected 
libraries, sequenced and tested in phage ELISA on the inverted SINEB2. 
Interestingly, ILF3 proved to be the unique clone giving a specific signal (Figure 
18), which was coherent with the higher fold enrichment emerged from sequencing 
data. Therefore, we decided to focus our attention on this extensively characterized 
double-stranded RNA-binding protein (dsRBP) regulating several steps of mRNAs 
life cycle (Castella et al., 2015). 
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Figure 18. Preliminary screening of higher-ranking ORFs. Specificity of clones SRSF5, 
HNRNPA3 and ILF3 was preliminary tested by phage ELISA on the inverted SINEB2. Streptavidin 
served as control. Values are indicated as the fold signal vs background (uncoated wells). 
ILF3 RNA-binding capability is mainly dependent on the presence of two double-
stranded RNA-binding motives (dsRBMs), referred to as dsRBM1 and dsRBM2, 
shared by ILF3 main isoforms (Figure 19B). In particular, ILF3 clone employed in 
preliminary phage ELISA corresponded to dsRBM2, which represented the most 
enriched ILF3 domain in all selections. Indeed, individual alignment of ILF3-related 
reads from selected libraries followed by protein blast revealed predominant 
mapping on ILF3 dsRBM2 (Figure 19A). A minor portion of sequences mapped 
instead on dsRBM1 and other domains. These observations were further supported 
by preliminary screening and sequencing of randomly picked clones from selected 
libraries (data not shown). Moreover, comparison of reads landscape in selected vs 
non-selected (NS) libraries allowed to confirm that ILF3 dsRBM2 enrichment was 
restricted to SINEUP baits-driven selections (both with AS Uchl1 ∆5’ and inverted 
SINEB2), thus excluding any artifacts coming from overrepresentation of the clone 
in the starting library (Figure 19A). 
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Figure 19.  DsRBM2 is specifically enriched in SINEUP-driven selections. (A) Reads alignment to 
ILF3 gene. Data relative to AS Uchl1 Δ5'_ssDNA (middle) and inverted SINEB2_ssDNA (bottom) 
selections are shown. DsRBM2 (black arrows) is enriched in selected libraries, but not in the 
unselected (NS, top) library. Blue bars (top) indicate the gene; green bars (bottom) correspond to 
exons. (B) Schematic representation of ILF3 domains in the two main protein isoforms (NF110 and 
NF90): NF45-homology domain; nuclear localization signal (NLS); double-stranded RNA-binding 
motives (dsRBM) 1 and 2; RGG motif; GQSY domain. Abbreviations: NF=nuclear factor (alias for 
ILF3). 
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Hence, we kept on validating binding of ILF3 dsRBM2 with each of the baits 
employed for selection by phage ELISA (Figure 20). 
 
 
Figure 20. In vitro validation of SINEUP/ILF3 interaction by phage ELISA. DsRBM2 was 
screened by phage ELISA on SINEUP baits. Streptavidin served as control. Values are indicated as 
the fold signal vs background (uncoated wells). 
Data showed that binding occurred with both AS Uchl1 ∆5’ and inverted SINEB2 in 
a similar fashion, thus corroborating the specific nature of SINEUP/ILF3 dsRBM2 
interaction in vitro. As further biochemical characterization, we were interested in 
comparing binding profiles of the two dsRBMs present in ILF3, differentially 
enriched during selections. Two representative ORFs encoding for ILF3 dsRBM1 
and dsRBM2, respectively, were thus cloned as GST-fusion polypeptides and 
screened in ELISA (Figure 21). 
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Figure 21. In vitro validation of SINEUP/ILF3 interaction by GST ELISA. Comparison between 
dsRBM1 and dsRBM2. Domains were subcloned into a compatible pGEX vector, purified as GST-
fusion polypeptides and screened on SINEUP baits. Data indicate mean ± st dev. Data are 
representative of n=3 independent replicas.  
Considering dsRBM2, results pointed out that binding occurred in a specific fashion 
with both baits. Notably, binding to AS Uchl1 ∆5’-embedded inverted SINEB2 was 
characterized by a higher signal/noise ratio. Conversely, dsRBM1-related ELISA 
signal was similar to the negative control with both baits.  
Taken together, these results support a direct binding between the inverted SINEB2 
and ILF3 dsRBM2, which provides the specific domain mediating the interaction 
with SINEUP baits in vitro.  Of notice, we registered a remarkable increase in GST 
ELISA signal when dsRBM2 was exposed to AS Uchl1 ∆5’-embedded inverted 
SINEB2. 
2.4 AS Uchl1 and ILF3 interact in vivo and binding requires the inverted 
SINEB2 repeat 
RNA-IP preliminary setup 
Once binding in vitro was validated, we focused on characterizing AS Uchl1/ILF3 
interaction in vivo by RNA-IP. To overcome technical difficulties arising from low 
expression of endogenous AS Uchl1 in cells, we decided to overexpress this and co-
immunoprecipitate it with endogenous ILF3.  
Since endogenous AS Uchl1 is mainly localized in the nucleus (Carrieri et al., 2012), 
we investigated the subcellular distribution of transfected AS Uchl1 in three different 
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cell lines: mouse neuronal dopaminergic (MN9D), mouse neuroblastoma (N2A) and 
human embryonic kidney (HEK) 293T/17. After carrying out subcellular 
fractionation, AS RNA levels in nuclear and cytoplasmic compartments were 
quantified by qRT-PCR and expressed as relative percentages of total AS RNA. 
Nuclear and cytoplasmic fractions purity was controlled by monitoring levels of 
GAPDH and pre-rRNA, respectively. Comparison of distribution patterns in different 
cell lines confirmed a predominant nuclear localization of exogenous AS Uchl1 in all 
cell lines, with >60% of AS RNA detected in nuclei (Figure 22). 
 
 
Figure 22. AS Uchl1 subcellular distribution in different cell lines. Subcellular distributions of 
overexpressed AS Uchl1 in HEK 293T/17, N2A and MN9D were compared. RNA quantification in 
cellular fractions was made by qRT-PCR. Nuclear (dark gray) and cytoplasmic (light gray) RNA 
levels were expressed as percentages of total RNA. Purity of fractions was assessed by evaluating 
levels of pre-rRNA and GAPDH.  Data are representative of three independent experiments and 
indicate mean ± st dev.  
In the same cells, we also investigated ILF3 localization by immunofluorescence 
(IF). Consistently with what found in literature, ILF3 was almost totally nuclear in all 
cells (Figure 23A). Of notice, in neuronal cells MN9D and N2A ILF3 staining was 
characterized by bright spots co-localizing with nucleoli. This has been shown 
previously, even if in a different line (Viranaicken et al., 2011), and is likely due to 
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the expression of a splicing variant predominantly found in nucleoli. In summary, 
these experiments confirmed the co-existence of overexpressed AS Uchl1 and 
endogenous ILF3 in the same cell compartment in different cell lines.  
We then completed ILF3 characterization by monitoring protein expression levels. 
WB analysis showed that our antibody was specifically recognizing the two main 
isoforms of ILF3 (NF90 and NF110, at 90 kDa and 110 kDa, respectively, Figure 
23B) in all cell lines. 
 
 
Figure 23. ILF3 in different cell lines. (A) IF on ILF3. Endogenous ILF3 was detected with anti-
ILF3 antibody. Cytoplasmic counter-staining was carried out with anti DJ-1 antibody in HEK 
293T/17 and N2A; in MN9D anti-TH antibody was used. Nuclei were stained with DAPI. (B) ILF3 
protein levels in different cell lines. Endogenous ILF3 protein levels were monitored by WB in HEK 
293T/17, MN9D and N2A. Immunoblotting was carried out with anti-ILF3 antibody. Actin-β was 
used as loading control. 
In particular, expression levels in HEK 293T/17 were considerably higher than in 
neuronal cells.  
Therefore, given their higher transfectability compared to neuronal lines and the 
higher expression of ILF3, we chose to carry out RNA-IP experiments in HEK 
293T/17.  
RNA-IP 
Following AS Uchl1 overexpression and cross-linking of RNA-protein complexes, 
endogenous ILF3 was immunoprecipitated with specific antibodies or control IgG. 
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As we were interested in addressing the contribution of SINEUP ED in protein 
binding in vivo, an AS Uchl1 mutant lacking the inverted SINEB2, referred to as AS 
Uchl1 ΔSINEB2 was also employed (described in Carrieri et al., 2012 and 
schematically represented in Figure 24A). Parallel RNA-IPs were thus performed 
with WT and ΔSINEB2 AS Uchl1, and enrichment patterns compared. The presence 
of target RNA in ILF3 IP fractions or control IgG was quantified by qRT-PCR and 
normalized to the mRNA level of the housekeeping gene Ubiquitin C (UBC), 
previously described as non-interacting with ILF3 (Kuwano et al., 2010). IP 
efficiency was monitored by western blot. As shown in figure Figure 24B, AS Uchl1 
was specifically enriched in ILF3 immunoprecipitates, confirming that AS Uchl1 and 
ILF3 interact in vivo. Of notice, WB analysis showed that both HEK endogenously 
expressed ILF3 isoforms, NF110 and NF90, were successfully immunoprecipitated 
(Figure 24C).   
 
Figure 24. Validation of AS Uchl1/ILF3 interaction in vivo. (A) Schematic representation of AS 
Uchl1 WT (left) and AS Uchl1 ΔSINEB2 (right). (B) Endogenous ILF3 co-IP with overexpressed AS 
Uchl1 WT or AS Uchl1 ΔSINEB2 was carried out in HEK 293T/17. As control of IP specificity, IgG 
were immunoprecipitated in parallel. WT or mutated AS Uchl1 enrichment in ILF3 IP or IgG was 
quantified by qRT-PCR (left) and expressed as (2^ ΔCT)*100 ILF3 IP/ (2^ ΔCT)*100 IgG. ΔCT was 
calculated on INPUT. RNA content in IgG/IP was normalized on UBC mRNA. (C) ILF3 IP efficiency 
was monitored by WB. Immunoblotting was performed with anti-ILF3 antibody, recognizing both 90 
KDa and 110 KDa ILF3 isoforms.  Data are representative of three independent experiments and 
indicate mean ± st dev. Differences with p<0.05 were considered significant. 
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Interestingly, removal of the inverted SINEB2 resulted in a remarkable decrease of 
AS RNA detected in ILF3 IP fraction (Figure 24B), suggesting a role of the 
embedded repeat in establishing contacts with this RBP. Taken together, these results 
support an interaction between AS Uchl1 and ILF3 in vivo and a crucial role of the 
embedded inverted SINEB2 repeat as interaction interface with the nuclear protein 
partner ILF3. 
2.5 The inverted SINEB2 and Alu direct localization of AS Uchl1 to ILF3-
containing nuclear complexes 
So far, we confirmed AS Uchl1/ILF3 binding in vitro and in vivo, pointing out the 
pivotal role of the ED in mediating contacts between transcript and protein in vivo. 
As a natural prosecution of such findings, we investigated the biological function of 
this interaction in cells. Transcripts with embedded TEs have been reported to be 
often retained in nuclei. Being privileged sites for editing (Athanasiadis et al., 2004; 
Kim et al., 2004; Levanon et al., 2004), repetitive elements and, in particular, SINEs 
often provide interfaces for association to nuclear protein complexes, which 
subsequently control their export and cytoplasmic availability (Chillón and Pyle, 
2016; Zhang and Carmichael, 2001). On the other hand, nuclear ILF3 has been 
shown to actively contribute to regulation of basic metabolic properties of RNAs, 
including subcellular localization and stability (Castella et al., 2015). In this context, 
we investigated the role of ILF3 in trapping SINEUPs in the nuclear compartment, 
via binding the inverted SINEB2. To address the involvement of ILF3 in modulating 
SINEUPs localization, we overexpressed AS Uchl1 in ILF3-silenced HEK 293T/17 
(Figure 25A) and checked its subcellular distribution by nucleocytoplasmic 
fractionation. Interestingly, data showed a 10-20% increase of AS Uchl1 WT in the 
cytoplasmic fraction of knocked-down cells (Figure 25B). 
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Figure 25. AS Uchl1 subcellular localization upon ILF3 silencing. (A) ILF3 was silenced in HEK 
293T/17 and (B) overexpressed WT AS Uchl1 subcellular localization was evaluated in knocked-
down cells (siILF3, gray bars) by nucleocytoplasmic fractionation. Control cells received WT AS 
Uchl1 and control siRNA (siCTRL, black bars). RNA quantification in cellular fractions was made by 
qRT-PCR. Nuclear (left) and cytoplasmic (right) RNA levels were expressed as percentages of total 
RNA. Purity of fractions was assessed by evaluating levels of pre-rRNA and GAPDH.  Data are 
representative of four independent experiments and indicate mean ± st dev. Differences with p<0.05 
were considered significant. 
As a complementary approach, we verified whether the inverted SINEB2 excision 
had any impact on AS Uchl1 localization. Therefore, we carried out cell fractionation 
from HEK 293T/17 transfected with AS Uchl1 WT or with its mutant deprived of the 
SINEB2. We observed that AS Uchl1 distribution was partially perturbed in response 
to removal of the inverted SINEB2, again with a 20% increase of AS RNA detected 
in the cytoplasmic compartment, compared to the WT variant. This was strikingly 
reminiscent of what observed following ILF3 silencing (Figure 26).  
Taken together, these data strengthen a role of ILF3 in AS Uchl1 nuclear entrapment 
through its interaction with the inverted SINEB2 element.  
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Figure 26. Subcellular localization of AS Uchl1 WT and its ΔSINEB2 mutant. Subcellular 
distributions of AS Uchl1 WT (black bars) and ΔSINEB2 (gray bars) were compared.  RNA 
quantification in cellular fractions was made by qRT-PCR. Nuclear (left) and cytoplasmic (right) 
RNA levels were expressed as percentages of total RNA. Purity of fractions was assessed by 
evaluating levels of pre-rRNA and GAPDH. Data are representative of four independent experiments 
and indicate mean ± st dev. Differences with p<0.05 were considered significant. 
However, the deletion of the inverted SINEB2 proved not to be sufficient for a 
complete relocalization of AS Uchl1 in the cytoplasm. In addition to the SINEB2, 
another repetitive element, that is a partial Alu sequence, was previously unmasked 
in the AS Uchl1 third exon (Carrieri et al., 2012). Though not necessary for 
translational activity, we decided it was interesting to investigate its potential role in 
AS Uchl1 subcellular localization. We thus assessed the effects of combined removal 
of the SINEB2 and the Alu repeat by taking advantage of AS Uchl1 Δ Transposable 
Elements (AS Uchl1 ΔTE) mutant (Figure 27A, right). Results showed a dramatic 
inversion of AS RNA distribution within the cell with 60-70% localizing in the 
cytoplasmic fraction (Figure 27B). 
  69 
 
Figure 27. Subcellular localization of AS Uchl1 ΔTE mutant. (A) Schematic representation of AS 
Uchl1 WT and AS Uchl1 ΔTE mutant. ΔTE results from combined removal of embedded inverted 
SINEB2 (red) and partial Alu (blue). (B) Subcellular distributions of WT AS Uchl1 (black bars) and 
ΔTE (gray bars) were compared. RNA quantification in cellular fractions was made by qRT-PCR.  
Nuclear (left) and cytoplasmic (right) RNA levels were expressed as percentages of total RNA. Purity 
of fractions was assessed by evaluating levels of pre-rRNA and GAPDH. Data are representative of 
four independent experiments and indicate mean ± st dev. Differences with p<0.05 were considered 
significant. 
To summarize, these results suggest that embedded repeats, SINEB2 and Alu, may 
act in a synergic fashion to produce the motif responsible for AS Uchl1 nuclear 
retention.  
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2.6 ILF3 interacts with paraspeckle protein p54nrb in vivo 
We then asked whether ILF3 could be part of a major nuclear complex in charge of 
regulating AS Uchl1 availability in the cytoplasm. Therefore we focused our 
attention on paraspeckles. These are subnuclear bodies localizing in the 
interchromatin space in the proximity of nuclear speckles (Fox and Lamond, 2010). 
Paraspeckles are critical to the control of gene expression through the nuclear retention 
of transcripts containing dsRNA regions that have been subject to A-to-I editing.  
We assessed the interaction between ILF3 with p54nrb, that is one of the main protein 
components of paraspeckles. To this purpose, we carried out an assay of co-IP of 
endogenous ILF3 and p54nrb in HEK 293T/17. Following protein extraction, lysates 
were analyzed by WB. As shown in Figure 28, p54nrb was enriched in ILF3 
immunoprecipitates, suggesting that the two proteins are likely to be found in the 
same complex in vivo. 
 
Figure 28. ILF3 interacts with paraspeckle protein p54nrb in vivo. Co-IP of ILF3 and p54nrb. 
Endogenous ILF3 was immunoprecipitated in HEK 293T/17 cells. ILF3 IP efficiency was revealed by 
immunoblotting with anti-ILF3 antibody. The presence of p54nrb in immunoprecipitates was assessed 
by probing the membrane with anti-p54nrb antibody. 
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3 Validation of SINEUPs as RNA tools to increase protein synthesis 
Attachment: “SINEUPs are modular AS long non-coding RNAs that increase 
synthesis of target proteins in cells” 
Similarly to proteins, AS Uchl1 and natural SINEUPs display discrete domains that 
in combination determine their function. The BD and the ED provide “modules” 
conferring specificity and biological activity, respectively. As previously shown with 
synthetic SINEUP AS GFP, the domain organization of AS Uchl1 can be exploited 
to engineer artificial RNAs enhancing translation of selected mRNAs (Carrieri et al., 
2012). These observations pave the way for the application of SINEUPs as tools to 
increase synthesis of target proteins in a number of different contexts.  
In biopharmaceutical industry, SINEUPs could be employed in systems for large-
scale production of recombinant proteins, with the clear advantage of increased 
purity of the target protein over contaminants.  
The use of SINEUPs as molecular biology reagents would sound promising as well. 
Indeed, from a certain perspective, SINEUPs can be considered as the opposite 
counterpart of siRNAs. As siRNAs have become a useful tool in the hands of 
experimental biologists when inhibition of gene expression is required to address 
specific biological questions, there are as many instances where scientists are 
interested in perturbing biological systems by increasing the amount of a specific 
endogenous protein, or a whole set of proteins, within physiological ranges.  
Eventually, SINEUP molecules may represent ideal RNA therapeutic tools for 
increasing gene expression in vivo. In particular, diseases arising from 
haploinsufficiency would strongly benefit from the discovery of RNAs that can 
increase protein levels of genes for which low expression is pathogenic. 
So far, the potential scalability of AS Uchl1-derived synthetic lncRNAs to a platform 
of mRNA-specific translation enhancers remains to be addressed.  
In the following attached paper, we validated and optimized SINEUPs as molecular 
tools to increase translation of selected targets.  
Validation came along different steps. First, we demonstrated the efficacy and 
reproducibility of synthetic SINEUPs in different cell lines. As the modular structure 
of SINEUPs theoretically allows the design and generation of synthetic SINEUPs 
against desired targets by swapping the BD with an appropriate sequence, we then 
  72 
tested the flexibility of BD design. To this purpose, we created a SINEUP targeting 
the commonly used FLAG tag sequence and showed that it successfully managed to 
up-regulate synthesis of different N-terminally FLAG-tagged proteins in cells, 
supporting interesting applications of SINEUPs in protein manufacturing. Next, we 
provided evidence about the activity of SINEUPs domains as independent units 
presenting their own structure and function. Indeed, SINEUP activity is retained in 
miniSINEUPs, which exclusively contain the BD and ED, isolated from the rest of 
AS Uchl1 sequence. MiniSINEUPs represent a miniaturized version of SINEUPs, 
within the range of small RNAs length, thus facilitating delivery in vivo.  Finally, we 
explored the potential application of synthetic SINEUPs to modulate endogenous 
genes expression. In this context, we successfully design SINEUPs targeting 
endogenous Parkinson’s disease-associated DJ-1 and validated activity in different 
neuronal cell lines.  
In summary, here we propose SINEUPs as scalable tools to increase synthesis of 
chosen proteins, with important applications in molecular biology experiments, 
protein manufacturing as well as in RNA-based molecular therapy. 
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Supplementary Figure 1. Treatment with stressful stimuli does not increase SINEUP activity in 
transfected cells. HEK 293T/17 cells were transfected with pEGFP in combination with SINEUP-GFP 
(+SINEUP) or control plasmid (-SINEUP). After transfection, cells were treated with rapamycin or 
doxorubicin as indicated. Lysates were probed anti-GFP antibody. β-actin was used as loading 
control. Fold-induction was calculated on Western blot images normalized to β-actin and relative to 
empty control samples. 
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Supplementary Figure 2. SINEUP RNA is detected in the cytoplasm of transfected cells. HEK 
293T/17 cells were transfected with pEGFP in combination with SINEUP-GFP (+SINEUP). RNA 
was purified from separated nuclear and cytoplasmic fractions. RNA was reverse transcribed and 
probed for SINEUP RNA and GFP mRNA, as indicated. Purity of nuclear and cytoplasmic fractions 
was monitored by qRT-PCR on precursor rRNA. Data were normalized to the level of GAPDH in 
each fraction and analyzed with the ΔΔCt method. RNA levels in the cytoplasm were set to 1. Data 
indicate mean ± standard deviation and are calculated on 3 independent replicas. 
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Supplementary Figure 3. SINEUP-increased targets can be detected with target-specific antibodies. 
HEK 293T/17 cells were transfected with pcDNA3-2XFLAG-TRAF6 in combination with SINEUP-
FLAG (+SINEUP) or control plasmid (-SINEUP). Lysates were probed anti-TRAF6 antibody. 
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Supplementary Figure 4. SINEUP-FLAG does not increase FLAG-TTRAP protein levels. HEK 
293T/17 cells were transfected with pcDNA3-2XFLAG-TTRAP in combination with SINEUP-FLAG 
(+SINEUP) or control plasmid (-SINEUP). Lysates were probed anti-FLAG antibody. SINEUP RNA 
and TTRAP mRNA were quantified by qRT-PCR with specific primers. Data indicate average ± stdev 
and are representative of n = 3 independent experiments. 
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DISCUSSION 
Recent advances in sequencing technologies have radically changed our view of 
RNA. The existence of thousands of non-coding transcripts suggests that RNA is 
indeed more than just a messenger between genes and proteins. The discovery of 
regulatory RNAs, such as miRNAs, siRNAs and lncRNAs revealed a previously 
underestimated complexity underlying gene expression regulatory networks. At the 
same time, it paved the way for potential uses of such RNAs as tools to modulate 
gene expression ad hoc in vitro and in vivo.  
Among ncRNAs, lncRNAs represent the major transcriptional output of mammalian 
cells. Even if the quest for function of lncRNAs is still on its way, a number of 
examples support their contribution to gene expression regulation through an array of 
different mechanisms (Huarte and Marín-Béjar, 2015). However, a common 
grammar seems to stand at the basis of their mode of action. Evidence suggests that 
lncRNAs work as flexible “modular scaffolds”, recruiting and coordinating different 
effectors through discrete RNA domains (Guttman and Rinn, 2012). RNA folding is 
now believed to provide functional cues to lncRNA domains, as these display poor 
conservation within their primary sequence.  
The use of lncRNAs as tools to modulate gene expression is vastly unexplored, 
partially due to limited knowledge of lncRNAs' structure/function relationship. 
Although a big challenge, unveiling the specific mechanisms ruling the activity of 
regulatory ncRNAs represents a crucial point for their application in diverse context, 
from biotechnology to therapy.  
In this study we investigated the molecular mechanisms underlying biological 
activity of natural and synthetic SINEUPs. These are AS lncRNAs able to increase 
translation of partially overlapping transcripts. Their biological activity relies on the 
presence of an embedded retrotransposon of the SINEB2 type, which represents 
SINEUPs ED. In particular, we demonstrated the structural basis for the activation of 
protein synthesis mediated by the inverted SINEB2. Furthermore, we provided 
evidence about the ED working as interaction interface with protein partner ILF3, 
which is involved in regulation of SINEUPs localization. Finally, we showed that, 
two embedded TEs (inverted SINEB2 and Alu) together serve as SINEUPs nuclear 
retention signal. In particular, these findings add further layer of complexity to the 
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role of the ED which, besides conferring translation activation power, contributes to 
tune SINEUPs action by regulating their location.  
After investigating the molecular rules of SINEUP activity, we focused on validating 
and optimizing synthetic SINEUPs as RNA tools to increase protein production. We 
eventually propose SINEUPs as the first scalable tool to increase synthesis of chosen 
proteins, with important applications in molecular biology experiments, protein 
manufacturing as well as in therapy. 
SINEUPs as a paradigm for lncRNAs structure and function 
The mouse genome contains approximately 350,000 SINEB2 sequences as 
independent transcriptional units or embedded in RNA polymerase II transcripts 
(Kramerov and Vassetzky, 2011a). Like all TEs, SINE elements have been originally 
presented as genomic parasites (Doolittle and Sapienza, 1980), due to the disruptive 
effects on gene expression caused by their insertions into coding or regulatory 
sequences in genomes. However, conversely to LINEs', SINEs insertions within 
coding regions seem to be more tolerated and have often resulted in the rise of 
functional elements of transcripts (Lander et al., 2001). In particular, “embedded” or 
“exonized” SINEs, as well as other TEs, have been recently proposed to work as 
portable domains responsible for lncRNAs regulatory functions  (Johnson and Guigó, 
2014; Kapusta and Feschotte, 2014; Zucchelli et al., 2015a; Carrieri et al., 2012). 
This is supported by many examples of repeat-rich, functional lncRNAs (Johnson 
and Guigó, 2014). A major issue to the “embedded domain” hypothesis is 
represented by the poor sequence conservation of lncRNAs during evolution. 
Different studies have reported that lncRNAs present highly conserved secondary 
and tertiary structures, which have been often shown to be related to their functions 
(Li et al., 2016). Theoretically, this concept may be applied to embedded TEs as 
well. Of notice, SINE elements have a highly conserved secondary structure that 
derives from the RNA species from which SINEs took their origin, that is tRNAs.  
Carrieri and colleagues showed that mouse lncRNA AS Uchl1 is capable of 
enhancing translation of sense protein-coding Uchl1 mRNA through an embedded 
retrotransposon of the SINE type (Carrieri et al., 2012). In this context, we exploited 
the modular organization and the well-defined biological function of AS Uchl1 to 
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address the issue of structural/functional relationship in lncRNA domains.  Previous 
data of chemical footprinting showed that the inverted SINEB2 mostly folds into 
helical structures, with several internal loops and hairpins. Similar structures have 
been reported to provide interfaces for specific recognition by molecular partners. 
For example, SRA (steroid receptor RNA activator), a breast cancer-linked lncRNA, 
which co-activates several nuclear receptors and proteins, is reported to have highly 
conserved helices, terminal loops, and bulges in many species (Novikova et al., 
2012). Moreover, as regards SINEs, an extended stem-loop structure, with terminal 
loops and internal bulges, has been previously observed for other SINE RNAs (Sun 
et al., 2007), positioned either at the 5’ end, as for BC1 (Rozhdestvensky et al., 
2001), or at the 3’ terminus, as in the case of salmon SmaI SINE (Kawagoe-Takaki et 
al., 2006). 
The deletion of the SL1 structural motif abolished the ability of AS Uchl1 to increase 
endogenous UCHL1 protein levels. This supports a role of SL1 as a structural 
determinant of AS Uchl1 activity. This model was further confirmed by the 
validation of a structure/function pattern in synthetic SINEUP AS GFP. Hence, 
common mechanisms of action are likely to underlie the biological activity of natural 
and synthetic SINEUPs. However, further studies are needed to understand whether 
SL1 motif is the unique ED portion determining biological activity of SINEUPs.  
According to mFOLD prediction (Appendix Figure 1), mutations characterizing AS 
Uchl1 delta SL1 exclusively result in disruption of the hairpin structure, without 
affecting the overall structural stability of the inverted SINEB2. This is in line with 
chemical footprinting data that indicate a stable “basal” structure of the molecule 
with a more flexible region at its “apical” part. Altogether, these results support a 
model of the invSINEB2 as an independent folding unit acting as ED thanks to a 
terminal stem loop structure.  
Recently Shein and collegues identified a lncRNA antisense to the human protein 
phosphatase 1 regulatory subunit 12A (PPP1R12A), named as R12A-AS1, that 
functions as SINEUPs in human cells.  R12A-AS1 overlaps the 5′ UTR and first 
coding exon of the PPP1R12A mRNA and contains a free right Alu monomer repeat 
element within its 3′ end. These domains are required for R12A-AS1-mediated 
PPP1R12A mRNA translation enhancement, coherently with what expected for 
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SINEUPs. Interestingly, a human SINE element -Alu monomer repeat- was for the 
first time found to provide for the domain conferring translation activity to SINEUPs, 
suggesting that different TEs can work as EDs (Schein et al., 2016).  It will be 
interesting to verify if similar structural determinants confer biological activity to 
both mouse and human embedded SINEs or, alternatively, if different structural 
determinants are associated with the same functional output. 
Phage display selection to identify SINEUP-binding proteins 
The modular architecture of natural and synthetic SINEUPs strongly support a role 
of embedded TEs as functional units of lncRNAs. Interestingly, a number of studies 
have demonstrated that TEs found in lncRNAs sequences can provide modules for 
association with molecular partners. For example, an embedded TE (Alu repeat) 
modulates ANRIL activity by recruiting protein components of the Polycomb 
Repressor Complex (Holdt et al., 2013). Binding of dsRBP Staufen and subsequent 
STAUFEN-mediated degradation is triggered by the formation of dsRNA following 
hybridization between mRNAs and lncRNAs containing complementary Alu 
fragments (Gong and Maquat, 2011).  
Previous data of chemical footprinting on the inverted SINEB2 from AS Uchl1 
revealed the presence of structural domains providing ideal interfaces for association 
with protein partners. One of these (SL1) was shown to be required for biological 
activity of natural and synthetic SINEUPs. Given the well established role of protein 
partners in modulating lncRNAs function, we asked whether the embedded inverted 
SINEB2 could provide the recognition site for specific protein complexes 
modulating SINEUP activity. To profile SINEUPs interactors, we applied the 
RIDome pipeline (Patrucco et al., 2015). This in vitro selection methodology 
combines phage display with NGS, thus allowing an unbiased, high-throughput 
characterization of RBDs interacting with desired target RNAs. Indeed, as an in vitro 
approach, it allows carrying out serial screenings on different targets. These can be 
either full-length RNAs or specific domains of interest. We decided to focus our 
attention on the inverted SINEB2, as the core domain of SINEUPs biological 
activity. In parallel, we carried out a wider investigation of SINEUP-binding proteins 
by selecting the library on AS Uchl1 Δ5’ RNA. This represents the common 
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backbone on which synthetic SINEUPs are built (Carrieri et al., 2012; Zucchelli et 
al., 2015b). Particularly, it contains the ED in an embedded format.  
Phage libraries can faithfully represent full-length proteomes or domainomes of cells, 
with the advantage of coupling phenotype to genotype identification. Of notice, when 
“filtered” ORFs domain libraries are employed for in vitro selection of targets, 
specific functional domains involved in bait-binding can be directly identified.  
The outcome of all selections consisted of a set of several hundreds genes. It is 
empirically known that most of them form the “noise” of the phage selection, as a 
large portion of these is represented by a reduced number of reads. Curiously, 
enrichment analysis revealed the presence of a clone by far more abundant than the 
others, in both inverted SINEB2 and AS Uchl1 Δ5’-driven selections. Similar results 
were observed when employing slightly different selection protocols with the same 
bait (i.e. ssDNA or tRNA as competitor), supporting the robustness of the selection 
procedure and the reliability of such result. The “top” clone corresponded to ILF3 
dsRBM2.  Preliminary biochemical validation of three differentially enriched RBPs 
(ILF3, SRSF5, HNRNPA3) commonly identified in different selections confirmed 
that differential enrichment did correspond to different binding specificity. Among 
these, ILF3 was the unique one specifically binding to the inverted SINEB2. This 
strengthens the importance of ELISA-based biochemical validation as first 
“specificity check point” along the pipeline. In this way, false positives arising from 
either technical limits of in vitro selection methodologies or possible artifacts 
introduced by NGS can thus be easily unmasked and excluded from subsequent 
validation steps.  
ILF3 in SINEUP biology 
ILF3 is a ubiquitously expressed dsRNA and DNA-binding protein. Firstly identified 
as a transcription factor in the IL-2 promoter-binding complex (Corthésy and Kao, 
1994; Kao et al., 1994), it has been later found to be involved in diverse processes 
besides transcription (splicing, translation, etc.) and, more generally, in RNA 
metabolism (transport, localization, stability, etc.). Although the specific biological 
functions of ILF3 are not precisely defined, the protein appears to be essential for 
cellular development and integrity (Castella et al., 2015). 
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Different protein isoforms are generated by a combination of alternative splicing and 
different polyadenylation events (Castella et al., 2015). The most abundant splicing 
variants are known as nuclear factor (NF) 90 and NF110, of 90 and 110 kDa, 
respectively. These proteins are basically identical, except for the presence of an 
additional region of ~200 aa within NF110 C-terminal. Their common region 
contains a predicted nuclear localization signal, two dsRBMs and an RGG-rich 
sequence, possibly interacting with a single stranded RNA (ssRNA) or a ssDNA. 
ILF3 RNA-binding capability mainly relies on the two dsRBMs, referred to as 
dsRBM1 and dsRBM2. Interestingly, individual alignment of ILF3 reads relative to 
both inverted SINEB2 and AS Uchl1 Δ5’-selected libraries showed dominant 
mapping on dsRBM2. Sequencing of the starting (non-selected) library confirmed 
that such enrichment was exclusively observed after selections.  
RNA recognition through dsRBDs is achieved by both sequence and shape 
determinants. In particular, hairpins apical loops provide “consensus” structures for 
dsRBPs (Masliah et al., 2013). A similar structural motif has been identified 
(Podbevšek et al., submitted) within the ED of SINEUPs, providing an optimal 
candidate domain mediating interactions with dsRBDs-containing proteins. 
Interestingly, a recent study reported that, together with structures, specific 
sequences in dsRNAs may affect target recognition by ILF3 dsRBMs, similarly to 
what happens for adenosine-to-inosine editing enzyme, ADAR2 (Jayachandran et al., 
2016). In particular, ADAR activity is triggered by the presence of long dsRNA 
stretches. In human, transcripts containing exonized Alus are extensively edited, as 
their high frequency results in the formation of dsRNA due to base-pairing between 
consecutive Alus IRAlus (Athanasiadis et al., 2004; Kim et al., 2004; Levanon et al., 
2004). Although the functional implications of ILF3/ADAR2 similarity are not clear, 
the hypothesis of ILF3 regulating ADAR2 activity by competing in binding with 
RNA seems reasonable. The association of ILF3 with a murine SINE would be 
coherent in such a scenario, even if the editing level in mouse SINEs is known to be 
much lower (Neeman et al., 2006).  
Validation of binding between clone dsRBM2 and SINEUP baits in vitro pointed out 
higher ELISA signal for AS Uchl1 Δ5’. We speculate that this might be linked to 
specific folding features of the inverted SINEB2 when present in an embedded 
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format. For example, the formation of extra-dsRNA regions can be triggered, 
improving binding affinity. As a further proof of the specific nature of ILF3 dsRBM2 
interaction with AS Uchl1, we stress that, in vitro, no binding has been observed with 
the other dsRBD present in ILF3 (dsRBM1). However, we cannot exclude the 
requirement of this domain in binding in vivo. Biochemical approaches provide in 
fact simplified models of the complex molecular dynamics characterizing 
interactions in cellular environments. Therefore, a crucial point was validation of AS 
Uchl1/ILF3 interaction in vivo. In particular, we were interested in assessing the 
requirement of the embedded inverted SINEB2 as domain mediating binding with 
ILF3 in vivo. Interestingly, we observed a reproducible enrichment AS Uchl1 RNA 
in endogenous ILF3 immunoprecipitates, which was remarkably reduced when the 
embedded inverted SINEB2 was removed. Coherently with what learnt from in vitro 
selection and validation, we thus demonstrated that binding with ILF3 is likely 
enabled by the inverted SINEB2. These findings strengthen the role of embedded 
TEs as functional domains mediating lncRNAs contacts with molecular partners 
(Johnson and Guigó, 2014; Carrieri et al., 2012; Zucchelli et al., 2015a).  
AS Uchl1 is predominantly found in nuclei of cells upon physiologic conditions, 
even if low levels of endogenous SINEUP RNA are always detected in the cytoplasm 
(Carrieri et al., 2012). Notably, even when overexpressed, AS Uchl1 keeps a 
predominant nuclear localization. Curiously, AS Uchl1-derived synthetic SINEUPs 
showed a similar distribution in cells (Zucchelli et al., 2015b), suggesting a common 
mechanisms determining subcellular fate for natural and synthetic SINEUPs. On the 
other hand, ILF3 is enriched in nuclei, even if it can shuttle to the cytoplasm during 
specific phases of cell cycle or upon certain stress stimuli (Parrott et al., 2005; 
Matsumoto-Taniura et al., 1996; Kuwano et al., 2008). We found that AS Uchl1 
localization is affected by ILF3 silencing, with a 10-20% increase of AS Uchl1 RNA 
detected in the cytoplasmic fraction. More interestingly, removal of the inverted 
SINEB2 phenocopied the distribution observed upon ILF3 knock-down. Hence, the 
inverted SINEB2 directs AS Uchl1 localization to ILF3-containing nuclear 
complexes, and is required to trap AS Uchl1 within cell nuclei. The ED is thus 
involved in regulating SINEUPs localization, likely providing an interface for 
association with ILF3-containing nuclear protein complexes. Similarly, even if not a 
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TE, a repetitive sequence named repeating RNA domain (RRD) in FIRRE lncRNA 
represents the binding site for nuclear protein hnRNP U. Conversely to ILF3, this 
protein is sufficient for sequestration of FIRRE in the nucleus. By engaging the RRD 
motif, the protein drives FIRRE focal localization at the site of transcription, where 
the lncRNA directs the formation of trans-chromosomal contacts (Hacisuleyman et 
al., 2014). Although both regulating localization, hnRNP U and ILF3 have opposite 
effects on their partners' s activity, which is enabled and inhibited, respectively.  
ILF3 is not sufficient to retain AS Uchl1 in the nucleus, suggesting that other nuclear 
proteins could be directly responsible for AS Uchl1 bias towards nuclear 
localization. In this context, we showed that ILF3 interacts with p54nrb, one of the 
core components of paraspeckles (Fox and Lamond, 2010). These are subnuclear 
bodies whose function is still unclear. They have been proposed to be involved in 
nuclear sequestration of specific factors, including repeat-containing edited RNAs 
(Prasanth et al., 2005). This would argue for a link between ILF3, editing and nuclear 
retention. So far these remain speculations, and further experiments should be carried 
out to investigate such hypothesis. Some evidence however exists in literature of 
ILF3 interacting with p54nrb, even if not in the context of paraspeckles (Yamauchi et 
al., 2012). 
TEs as nuclear localization signals of SINEUPs 
A considerable portion of AS Uchl1 deleted of the inverted SINEB2 was still found 
in the nuclear compartment. We thus investigated the presence of other sequences 
involved in regulation of SINEUPs location, focusing on the partial Alu repeat 
present immediately downstream the inverted SINEB2. Strikingly, combined 
removal of inverted SINEB2 and Alu significantly perturbed AS Uchl1 distribution 
across the cell, with about 70% shuffling to the cytoplasmic compartment. Recently, 
IRAlus contained in lincRNA-p21 have been shown to fold into specific structures 
required for nuclear localization. Indeed, mutations disrupting such secondary 
structures resulted in altered lincRNA-p21 distribution (Chillón and Pyle, 2016). It 
would be tempting to hypothesize a similar mechanism underlying cytoplasmic 
location of AS Uchl1 lacking both TEs, SINEB2 and Alu. Tandem inverted SINEB2 
and Alu elements would in this context provide “unconventional” inverted repeats 
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dictating SINEUPs nuclear localization. Coherently, heterodimeric structures of 
SINEs belonging to different families have been reported previously (i.e. 7SL 
RNA/tRNA) (Kramerov and Vassetzky, 2011b), even if no specific function have 
been assigned to these yet. 
Embedded TEs of synthetic SINEUPs are of murine origin; it is interesting to notice 
that they work as nuclear localization signal even in human cell lines (HEK 
293T/17). A different situation occurs with FIRRE RRD, which has been shown to 
work as species-specific nuclear localization signal in Sox2 mRNA chimeras, in a 
hnRNP U-dependent fashion (Hacisuleyman et al., 2016).  
As a consequence of the absence of the ED, AS Uchl1 mutants lacking TEs are 
predominantly found in the cytoplasm; however, they are not functional. This 
suggests that the cytoplasmic availability of functional SINEUPs is likely under strict 
control. Hence, it might exist a pool of cellular nuclear-retained RNAs normally kept 
latent in the nucleus, that are ready to respond to acute stimuli by changing their 
subcellular localization. An example fulfilling this model is represented by mouse 
CTN-RNA. This is retained in the nucleus but, following stress-induced post-
transcriptional cleavage of its 3' end, is efficiently exported and translated. 
Noteworthy, three inverted repeats of SINE origin are present within its 3' end and 
are likely involved in CTN-RNA sequestration (Prasanth et al., 2005). As CTN-RNA 
has been proposed as non-coding nuclear reservoir of coding mRNAs, we can infer 
that natural SINEUPs are stored in nuclei as “inactive” molecules, but they can 
rapidly be transferred to translation sites within the cytoplasm in order to face 
specific cell needs. However, if we partially unveiled some of the mechanisms 
regulating nuclear retention, the molecular dynamics underlying SINEUPs export 
still await further exploration. 
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SINEUPs as versatile tools to increase translation of selected target mRNAs 
The potential use of AS Uchl1-derived lncRNAs as enhancers of target mRNAs 
translation opens the way to interesting biotechnological and therapeutical 
applications. As shown previously (Carrieri et al., 2012), by exploiting the 
characteristic modular architecture of natural SINEUPs, it is indeed possible to 
engineer synthetic SINEUPs directed against desired targets by solely manipulating 
the BD. Hence, SINEUPs represent a powerful tool to modulate gene expression in 
vitro and in vivo. In this context, two are the main advantages of SINEUP 
technology: 1) no stable genomic changes are introduced and 2) a gentle increase of 
selected proteins, within physiological ranges, is achieved. These features determine 
the applicability of SINEUPs as reagents for molecular biology, when increasing the 
amount of a specific protein is required. SINEUPs may be designed to protein tags 
commonly used in eukaryotic expression systems, with a single SINEUP 
theoretically being able to target several N-terminally tagged proteins. We showed 
this ability with SINEUP-FLAG and other groups provide similar experimental 
evidence with SINEUPs against HA and GFP tags (Yao et al., 2015).  
A crucial point was the demonstration that synthetic SINEUPs are capable of acting 
on protein coding transcripts of mammalian cells that do not present endogenous 
SINEUPs. To this, we design a synthetic SINEUP targeting endogenous Parkinson’s 
disease-associated DJ-1. This proved to be efficient in manipulating DJ-1 expression 
within physiological ranges, thus paving the way for employment of SINEUPs in 
therapy. As the main limitation in application of SINEUPs as naked RNA 
therapeutics is delivery of long molecules, we aimed at synthesizing the shortest 
functional miniSINEUP, in which BD and ED represent the only retained sequences. 
MiniSINEUPs keep biological activity in a miniaturized version within the range of 
small RNAs length. In particular, the activity of miniSINEUPs, where BD and ED 
are isolated from the rest of the sequence, represent the formal prove that SINEUPs 
domains work as independent units presenting their own structure and function.  
RNA therapeutics provides a huge potential in increasing the range of targets beyond 
the scope of existing pharmacological drugs (Gustincich et al., 2016). In this context, 
SINEUPs and miniSINEUPs molecules may represent an ideal tool for increasing 
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gene expression in vivo for therapy. In particular, SINEUPs would provide ideal 
therapeutic tools for treatment of haploinsufficiency, as well as many complex and 
metabolic diseases where the increase of pro-survival factors and dysregulated 
enzymes may impact the well being of patients. In principle, SINEUPs would act on 
the target mRNA under its physiological regulation in vivo, limiting adverse 
influences on the tissue. Even if in vivo application of SINEUPs is still in its infancy, 
two recent studies reported the efficacy of SINEUPs in modulating gene expression 
in vivo, encouraging their use as RNA drugs for the future (Indrieri et al., 2016; Long 
et al., 2016). 
Eventually, considering their effect on translation, SINEUPs may find applications in 
protein manufacturing (Zucchelli et al., 2016; Patrucco et al., 2015b). A number of 
therapeutic proteins are currently in use and many more are under development, 
including antibodies (Leader et al., 2008). In this field, optimization of culture yield 
represents a main issue (Bandaranayake and Almo, 2014). We and other groups 
(Patrucco et al., 2015b) demonstrated that SINEUP technology can be exploited, in 
combination with existing platforms, to improve the efficiency of such processes. 
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APPENDIX 
 
 
Appendix Figure 1. Prediction of wild type (left) and mutated (right) AS Uchl1 inverted SINEB2 
secondary structure. Secondary structure models were generated using mFOLD software. The blue 
square highlights the stem-loop 1 (SL1). 
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Intersected Selections Total Elements Elements ID 
AS Uchl1 Δ5’_tRNA 
AS Uchl1 Δ5’_ssDNA 
inverted SINEB2_tRNA 
inverted SINEB2_ssDNA 
 
18 CCDC124 
DNTTIP1 
HNRNPA3 
ILF3 
LOC400550 
MTND4P12 
NEAT1 
PAM 
PCBD2 
PPM1G 
RPN1 
SENP3 
SENP3-EIF4A1 
STX1A 
UBXN1 
VAT1 
VPS41 
WIBG  
 
Appendix Table 1. List of clones (alphabetic order) common to AS Uchl1 Δ5’_tRNA, AS Uchl1 
Δ5’_ssDNA, inverted SINEB2_tRNA, inverted SINEB2_ssDNA phage display selections. In bold are 
ORFs chosen for preliminary validation.  
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Intersected Selections Total Elements Elements ID 
AS Uchl1 Δ5’_tRNA 
inverted SINEB2_tRNA 
inverted SINEB2_ssDNA 
 
16 AP3D1 
DAB2 
DNAJB2 
EBF4 
ILF3 
MBTPS1 
MDH2 
MTND5P11 
NARF 
PEA15 
PFKL 
PHC1 
PKN1 
SCAMP3 
SPON2 
SRSF5 
 
Appendix Table 2. List of clones (alphabetic order) common to AS Uchl1 Δ5’_tRNA, inverted 
SINEB2_tRNA, inverted SINEB2_ssDNA phage display selections. In bold are ORFs chosen for 
preliminary validation. 
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Appendix Figure 2. Total RNA in ILF3-silenced and control HEK 293T/17. Total RNA levels of 
AS Uchl1, pre-rRNA and GAPDH were quatified by qRT-PCR. Values were normalizad on beta 
actin. No significative differences in total RNA content between siCTRL (white bars) and siILF3 
(black bars) samples were detected. Data are representative of three independent experiments and 
indicate mean ± st dev. 
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